Striatal	O
Transcriptome	O
and	O
Interactome	O
Analysis	O
of	O
Shank3	B-GP
-	O
overexpressing	O
Mice	B-OG
Reveals	O
the	O
Connectivity	O
between	O
Shank3	B-GP
and	O
mTORC1	B-GP
Signaling	O

Edited	O
by	O
:	O
Michael	O
R	O
.	O

Kreutz	O
,	O
Leibniz	O
Institute	O
for	O
Neurobiology	O
,	O
Germany	O

Reviewed	O
by	O
:	O
Andreas	O
Martin	O
Grabrucker	O
,	O
University	O
of	O
Limerick	O
,	O
Ireland	O
;	O
Michael	O
J	O
.	O

Schmeisser	O
,	O
Otto	O
-	O
von	O
-	O
Guericke	O
University	O
Magdeburg	O
,	O
Germany	O
;	O
Chiara	O
Verpelli	O
,	O
Istituto	O
di	O
Neuroscienze	O
(	O
CNR	O
),	O
Italy	O

Mania	B-DS
causes	O
symptoms	O
of	O
hyperactivity	O
,	O
impulsivity	O
,	O
elevated	O
mood	O
,	O
reduced	O
anxiety	B-DS
and	O
decreased	O
need	O
for	O
sleep	O
,	O
which	O
suggests	O
that	O
the	O
dysfunction	O
of	O
the	O
striatum	O
,	O
a	O
critical	O
component	O
of	O
the	O
brain	O
motor	O
and	O
reward	O
system	O
,	O
can	O
be	O
causally	O
associated	O
with	O
mania	B-DS
.	O

However	O
,	O
detailed	O
molecular	O
pathophysiology	O
underlying	O
the	O
striatal	O
dysfunction	O
in	O
mania	B-DS
remains	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
identify	O
the	O
molecular	O
pathways	O
showing	O
alterations	O
in	O
the	O
striatum	O
of	O
SH3	B-GP
and	I-GP
multiple	I-GP
ankyrin	I-GP
repeat	I-GP
domains	I-GP
3	I-GP
(	O
Shank3	B-GP
)-	O
overexpressing	O
transgenic	O
(	O
TG	O
)	O
mice	B-OG
that	O
display	O
manic	O
-	O
like	O
behaviors	O
.	O

The	O
results	O
of	O
transcriptome	O
analysis	O
suggested	O
that	O
mammalian	B-GP
target	I-GP
of	I-GP
rapamycin	I-GP
complex	I-GP
1	I-GP
(	O
mTORC1	B-GP
)	O
signaling	O
may	O
be	O
the	O
primary	O
molecular	O
signature	O
altered	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
.	O

Indeed	O
,	O
we	O
found	O
that	O
striatal	O
mTORC1	B-GP
activity	O
,	O
as	O
measured	O
by	O
mTOR	B-GP
S2448	O
phosphorylation	O
,	O
was	O
significantly	O
decreased	O
in	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
compared	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-OG
.	O

To	O
elucidate	O
the	O
potential	O
underlying	O
mechanism	O
,	O
we	O
re	O
-	O
analyzed	O
previously	O
reported	O
protein	O
interactomes	O
,	O
and	O
detected	O
a	O
high	O
connectivity	O
between	O
Shank3	B-GP
and	O
several	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
,	O
such	O
as	O
tuberous	B-GP
sclerosis	I-GP
1	I-GP
(	O
TSC1	B-GP
),	O
TSC2	B-GP
and	O
Ras	B-GP
homolog	I-GP
enriched	I-GP
in	I-GP
striatum	I-GP
(	O
Rhes	B-GP
),	O
via	O
94	O
common	O
interactors	O
that	O
we	O
denominated	O
“	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
”.	O

We	O
noticed	O
that	O
,	O
among	O
the	O
94	O
common	O
interactors	O
,	O
11	O
proteins	O
were	O
related	O
to	O
actin	B-GP
filaments	O
,	O
the	O
level	O
of	O
which	O
was	O
increased	O
in	O
the	O
dorsal	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Furthermore	O
,	O
we	O
could	O
co	O
-	O
immunoprecipitate	O
Shank3	B-GP
,	O
Rhes	B-GP
and	O
Wiskott	B-GP
-	I-GP
Aldrich	I-GP
syndrome	I-GP
protein	I-GP
family	I-GP
verprolin	I-GP
-	I-GP
homologous	I-GP
protein	I-GP
1	I-GP
(	O
WAVE1	B-GP
)	O
proteins	O
from	O
the	O
striatal	O
lysate	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

By	O
comparing	O
with	O
the	O
gene	O
sets	O
of	O
psychiatric	B-DS
disorders	I-DS
,	O
we	O
also	O
observed	O
that	O
the	O
94	O
proteins	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
were	O
significantly	O
associated	O
with	O
bipolar	B-DS
disorder	I-DS
(	O
BD	B-DS
).	O

Altogether	O
,	O
our	O
results	O
suggest	O
a	O
protein	O
interaction	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
certain	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
that	O
might	O
contribute	O
to	O
the	O
abnormal	O
striatal	O
mTORC1	B-GP
activity	O
and	O
to	O
the	O
manic	O
-	O
like	O
behaviors	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Introduction	O

Bipolar	B-DS
disorder	I-DS
(	O
BD	B-DS
),	O
characterized	O
by	O
recurrent	O
mood	O
swings	O
between	O
depression	O
and	O
mania	B-DS
,	O
is	O
a	O
highly	O
heritable	O
and	O
chronic	B-DS
mental	I-DS
illness	I-DS
that	O
affects	O
approximately	O
2	O
.	O
5	O
%	O
of	O
the	O
population	O
worldwide	O
(	O
Merikangas	O
et	O
al	O
.,	O
2011	O
).	O

Manic	B-DS
episodes	I-DS
are	O
the	O
defining	O
feature	O
of	O
BD	B-DS
,	O
and	O
manic	O
symptoms	O
include	O
hyperactivity	O
,	O
impulsivity	O
,	O
elevated	O
mood	O
,	O
reduced	O
anxiety	B-DS
and	O
decreased	O
need	O
for	O
sleep	O
(	O
Grande	O
et	O
al	O
.,	O
2016	O
).	O

These	O
core	O
symptoms	O
suggest	O
that	O
a	O
dysfunction	O
of	O
the	O
striatum	O
,	O
the	O
key	O
component	O
of	O
the	O
brain	O
motor	O
and	O
reward	O
systems	O
,	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
manic	B-DS
disorder	I-DS
.	O

This	O
hypothesis	O
is	O
supported	O
by	O
structural	O
and	O
functional	O
abnormalities	O
observed	O
in	O
the	O
striatum	O
of	O
the	O
patients	O
with	O
BD	B-DS
(	O
Strakowski	O
et	O
al	O
.,	O
1999	O
;	O
Blumberg	O
et	O
al	O
.,	O
2003	O
;	O
Wessa	O
et	O
al	O
.,	O
2007	O
).	O

However	O
,	O
the	O
detailed	O
molecular	O
pathophysiology	O
underlying	O
striatal	O
dysfunction	O
in	O
mania	B-DS
remains	O
largely	O
unknown	O
.	O

The	O
mammalian	B-GP
target	I-GP
of	I-GP
rapamycin	I-GP
(	O
mTOR	B-GP
)	O
pathway	O
integrates	O
various	O
external	O
signals	O
and	O
controls	O
diverse	O
cellular	O
processes	O
including	O
translation	O
,	O
apoptosis	O
,	O
autophagy	O
and	O
energy	O
metabolism	O
(	O
Laplante	O
and	O
Sabatini	O
,	O
2012	O
).	O

The	O
serine	B-GP
/	I-GP
threonine	I-GP
kinase	I-GP
mTOR	B-GP
forms	O
two	O
protein	O
complexes	O
,	O
mTOR	B-GP
complex	I-GP
1	I-GP
(	O
mTORC1	B-GP
)	O
and	O
mTORC2	B-GP
,	O
which	O
have	O
different	O
subunit	O
compositions	O
and	O
cellular	O
functions	O
.	O

The	O
heterodimeric	O
complex	O
of	O
tuberous	B-GP
sclerosis	I-GP
1	I-GP
(	O
TSC1	B-GP
)	O
and	O
TSC2	B-GP
is	O
a	O
critical	O
upstream	O
regulator	O
of	O
mTORC1	B-GP
that	O
functions	O
as	O
a	O
guanosine	O
triphosphatase	O
(	O
GTPase	O
)-	O
activating	O
protein	O
(	O
GAP	B-GP
)	O
for	O
the	O
small	B-GP
GTPase	I-GP
Ras	B-GP
homolog	I-GP
enriched	I-GP
in	I-GP
brain	I-GP
(	O
Rheb	B-GP
;	O
Huang	O
and	O
Manning	O
,	O
2008	O
).	O

As	O
the	O
active	O
(	O
GTP	O
-	O
bound	O
)	O
form	O
of	O
Rheb	B-GP
directly	O
binds	O
and	O
activates	O
mTORC1	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
complex	O
is	O
a	O
negative	O
regulator	O
of	O
mTORC1	B-GP
pathway	O
.	O

In	O
the	O
striatum	O
,	O
Ras	B-GP
homolog	I-GP
enriched	I-GP
in	I-GP
striatum	I-GP
(	O
Rhes	B-GP
,	O
encoded	O
by	O
Rasd2	B-GP
gene	O
),	O
a	O
small	B-GP
GTPase	I-GP
highly	O
enriched	O
in	O
the	O
striatal	O
medium	O
spiny	O
neurons	O
(	O
MSNs	O
),	O
has	O
roles	O
similar	O
to	O
Rheb	B-GP
in	O
directly	O
binding	O
and	O
activating	O
mTORC1	B-GP
in	O
a	O
GTP	O
-	O
dependent	O
manner	O
(	O
Subramaniam	O
et	O
al	O
.,	O
2011	O
).	O

The	O
activity	O
of	O
Rhes	B-GP
is	O
regulated	O
by	O
Ras	B-GP
guanyl	I-GP
releasing	I-GP
protein	I-GP
1	I-GP
(	O
RasGRP1	B-GP
),	O
a	O
guanine	B-GP
nucleotide	I-GP
exchange	I-GP
factor	I-GP
(	O
GEF	B-GP
),	O
in	O
the	O
striatum	O
(	O
Shahani	O
et	O
al	O
.,	O
2016	O
).	O

In	O
the	O
brain	O
,	O
the	O
mTOR	B-GP
pathway	O
is	O
involved	O
in	O
various	O
aspects	O
of	O
neuronal	O
development	O
and	O
function	O
including	O
dendrite	O
formation	O
,	O
axonal	O
elongation	O
and	O
synapse	O
formation	O
and	O
plasticity	O
(	O
Hoeffer	O
and	O
Klann	O
,	O
2010	O
;	O
Takei	O
and	O
Nawa	O
,	O
2014	O
).	O

This	O
pathway	O
has	O
critical	O
roles	O
in	O
normal	O
brain	O
function	O
,	O
as	O
abnormalities	O
in	O
the	O
expression	O
and	O
/	O
or	O
activity	O
of	O
its	O
upstream	O
and	O
downstream	O
components	O
have	O
been	O
identified	O
in	O
numerous	O
neurodevelopmental	O
and	O
neuropsychiatric	B-DS
disorders	I-DS
,	O
including	O
autism	B-DS
spectrum	I-DS
disorders	I-DS
(	O
ASDs	B-DS
),	O
drug	B-DS
addiction	I-DS
,	O
intellectual	B-DS
disability	I-DS
(	O
ID	B-DS
),	O
major	B-DS
depressive	I-DS
disorder	I-DS
(	O
MDD	B-DS
),	O
and	O
schizophrenia	B-DS
(	O
SCZ	B-DS
;	O
Costa	O
-	O
Mattioli	O
and	O
Monteggia	O
,	O
2013	O
).	O

Specifically	O
,	O
it	O
has	O
been	O
shown	O
that	O
mTORC1	B-GP
pathway	O
is	O
compromised	O
in	O
the	O
prefrontal	O
cortex	O
of	O
patients	O
with	O
MDD	B-DS
(	O
Jernigan	O
et	O
al	O
.,	O
2011	O
).	O

Furthermore	O
,	O
the	O
therapeutic	O
efficacy	O
of	O
a	O
fast	O
-	O
acting	O
antidepressant	O
ketamine	O
is	O
dependent	O
on	O
the	O
activation	O
of	O
mTORC1	B-GP
pathway	O
that	O
increases	O
the	O
synthesis	O
of	O
excitatory	O
synaptic	O
proteins	O
(	O
such	O
as	O
PSD	B-GP
-	I-GP
95	I-GP
and	O
glutamate	B-GP
receptors	I-GP
)	O
and	O
the	O
number	O
of	O
dendritic	O
spines	O
in	O
the	O
prefrontal	O
cortex	O
(	O
Li	O
et	O
al	O
.,	O
2010	O
;	O
Abdallah	O
et	O
al	O
.,	O
2015	O
).	O

However	O
,	O
potential	O
alterations	O
of	O
the	O
mTOR	B-GP
pathway	O
in	O
the	O
striatum	O
of	O
the	O
patients	O
with	O
mania	B-DS
have	O
been	O
scarcely	O
investigated	O
.	O

Several	O
pharmacological	O
and	O
genetic	O
rodent	B-OG
models	O
of	O
mania	B-DS
have	O
been	O
generated	O
and	O
characterized	O
,	O
and	O
these	O
,	O
even	O
with	O
some	O
limitations	O
,	O
have	O
provided	O
important	O
insights	O
towards	O
understanding	O
the	O
pathogenic	O
mechanisms	O
in	O
mania	B-DS
(	O
Chen	O
G	O
.	O
et	O
al	O
.,	O
2010	O
;	O
Kato	O
et	O
al	O
.,	O
2016	O
;	O
Logan	O
and	O
McClung	O
,	O
2016	O
).	O

We	O
recently	O
reported	O
that	O
EGFP	B-GP
-	O
Shank3	B-GP
(	O
SH3	B-GP
and	I-GP
multiple	I-GP
ankyrin	I-GP
repeat	I-GP
domains	I-GP
3	I-GP
)-	O
overexpressing	O
transgenic	O
(	O
TG	O
)	O
mice	B-OG
display	O
manic	O
-	O
like	O
behaviors	O
at	O
the	O
adult	O
stage	O
(	O
8	O
to	O
12	O
-	O
week	O
-	O
old	O
),	O
such	O
as	O
locomotor	O
hyperactivity	O
,	O
hypersensitivity	O
to	O
amphetamine	O
,	O
increased	O
acoustic	O
startle	O
response	O
,	O
reduced	O
prepulse	O
inhibition	O
and	O
abnormal	O
circadian	O
rhythms	O
.	O

Although	O
some	O
of	O
the	O
behavioral	O
abnormalities	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
could	O
also	O
be	O
observed	O
in	O
mice	B-OG
modeling	O
other	O
disorders	O
such	O
as	O
ASDs	B-DS
and	O
SCZ	B-DS
,	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
responded	O
to	O
valproic	O
acid	O
,	O
a	O
Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)-	O
approved	O
drug	O
for	O
the	O
treatment	O
of	O
manic	O
or	O
mixed	O
episodes	O
in	O
BD	B-DS
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

The	O
Shank3	B-GP
TG	O
mice	B-OG
mildly	O
overexpress	O
Shank3	B-GP
proteins	O
(	O
by	O
approximately	O
50	O
%)	O
compared	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-OG
,	O
and	O
thus	O
,	O
could	O
potentially	O
model	O
human	B-OG
patients	O
with	O
SHANK3	B-GP
gene	O
duplications	O
who	O
usually	O
have	O
an	O
additional	O
copy	O
of	O
SHANK3	B-GP
gene	O
.	O

Indeed	O
,	O
we	O
could	O
also	O
identify	O
several	O
patients	O
with	O
SHANK3	B-GP
gene	O
duplications	O
who	O
were	O
diagnosed	O
with	O
mania	B-DS
-	O
like	O
hyperkinetic	B-DS
disorders	I-DS
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

These	O
results	O
altogether	O
support	O
the	O
construct	O
,	O
face	O
and	O
predictive	O
validity	O
(	O
Nestler	O
and	O
Hyman	O
,	O
2010	O
)	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
to	O
model	O
human	B-OG
mania	B-DS
.	O

However	O
,	O
importantly	O
,	O
it	O
needs	O
to	O
be	O
validated	O
whether	O
the	O
SHANK3	B-GP
duplication	O
patients	O
with	O
mania	B-DS
-	O
like	O
hyperkinetic	B-DS
disorders	I-DS
indeed	O
express	O
higher	O
Shank3	B-GP
protein	O
levels	O
.	O

It	O
is	O
also	O
notable	O
that	O
SHANK3	B-GP
duplications	O
have	O
been	O
identified	O
in	O
patients	O
with	O
some	O
other	O
disorders	O
including	O
Asperger	B-DS
’	I-DS
s	I-DS
syndrome	I-DS
,	O
SCZ	B-DS
,	O
and	O
attention	B-DS
deficit	I-DS
hyperactivity	I-DS
disorder	I-DS
(	O
ADHD	B-DS
;	O
Durand	O
et	O
al	O
.,	O
2007	O
;	O
Failla	O
et	O
al	O
.,	O
2007	O
;	O
Moessner	O
et	O
al	O
.,	O
2007	O
).	O

In	O
addition	O
to	O
the	O
behavioral	O
phenotypes	O
,	O
we	O
also	O
showed	O
abnormalities	O
of	O
synaptic	O
actin	B-GP
cytoskeleton	O
and	O
dendritic	O
spines	O
in	O
the	O
hippocampus	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

Nevertheless	O
,	O
the	O
hippocampus	O
might	O
not	O
be	O
the	O
primary	O
brain	O
region	O
mediating	O
manic	O
-	O
like	O
behaviors	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
especially	O
considering	O
that	O
Shank3	B-GP
is	O
enriched	O
in	O
the	O
striatum	O
compared	O
to	O
other	O
brain	O
regions	O
(	O
Peça	O
et	O
al	O
.,	O
2011	O
;	O
Monteiro	O
and	O
Feng	O
,	O
2017	O
).	O

Moreover	O
,	O
the	O
identity	O
of	O
downstream	O
signaling	O
pathways	O
that	O
may	O
be	O
affected	O
by	O
altered	O
synaptic	O
actin	B-GP
cytoskeleton	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
remains	O
uninvestigated	O
.	O

SHANK3	B-GP
(	O
also	O
called	O
ProSAP2	B-GP
for	O
proline	B-GP
-	I-GP
rich	I-GP
synapse	I-GP
-	I-GP
associated	I-GP
protein	I-GP
2	I-GP
)	O
gene	O
encodes	O
a	O
core	O
scaffold	B-GP
protein	I-GP
organizing	O
the	O
macromolecular	O
protein	O
complex	O
of	O
the	O
neuronal	O
excitatory	O
postsynapse	O
(	O
Sheng	O
and	O
Kim	O
,	O
2000	O
;	O
Dosemeci	O
et	O
al	O
.,	O
2016	O
).	O

In	O
addition	O
to	O
duplications	O
,	O
deletions	O
and	O
various	O
point	O
mutations	O
of	O
SHANK3	B-GP
gene	O
have	O
been	O
causally	O
associated	O
with	O
ASDs	B-DS
,	O
ID	B-DS
and	O
SCZ	B-DS
(	O
Durand	O
et	O
al	O
.,	O
2007	O
;	O
Gauthier	O
et	O
al	O
.,	O
2010	O
;	O
Grabrucker	O
et	O
al	O
.,	O
2011	O
;	O
Jiang	O
and	O
Ehlers	O
,	O
2013	O
;	O
Guilmatre	O
et	O
al	O
.,	O
2014	O
;	O
Leblond	O
et	O
al	O
.,	O
2014	O
;	O
Choi	O
et	O
al	O
.,	O
2015	O
;	O
Monteiro	O
and	O
Feng	O
,	O
2017	O
).	O

Notably	O
,	O
several	O
studies	O
investigating	O
Shank3	B-GP
knock	O
-	O
out	O
(	O
KO	O
)	O
mice	B-OG
and	O
Shank3	B-GP
knock	O
-	O
down	O
in	O
neurons	O
revealed	O
that	O
the	O
loss	O
of	O
Shank3	B-GP
expression	O
results	O
in	O
changes	O
of	O
specific	O
signaling	O
pathways	O
such	O
as	O
metabotropic	B-GP
glutamate	I-GP
receptor	I-GP
5	I-GP
(	O
mGluR5	B-GP
)	O
signaling	O
(	O
Verpelli	O
et	O
al	O
.,	O
2011	O
;	O
Wang	O
et	O
al	O
.,	O
2016	O
;	O
Vicidomini	O
et	O
al	O
.,	O
2017	O
),	O
and	O
protein	B-GP
kinase	I-GP
B	I-GP
(	O
PKB	B-GP
/	O
Akt	B-GP
)-	O
mTOR	B-GP
signaling	O
(	O
Bidinosti	O
et	O
al	O
.,	O
2016	O
).	O

Moreover	O
,	O
pharmacological	O
treatments	O
(	O
mGluR5	B-GP
modulators	O
,	O
insulin	B-GP
-	I-GP
like	I-GP
growth	I-GP
factor	I-GP
1	I-GP
(	O
IGF1	B-GP
),	O
or	O
Cdc2	B-GP
-	I-GP
like	I-GP
kinase	I-GP
2	I-GP
(	O
CLK2	B-GP
)	O
inhibitor	O
)	O
targeting	O
these	O
pathways	O
recued	O
both	O
synaptic	O
and	O
behavioral	O
abnormalities	O
caused	O
by	O
the	O
loss	O
of	O
Shank3	B-GP
expression	O
(	O
Bozdagi	O
et	O
al	O
.,	O
2013	O
;	O
Shcheglovitov	O
et	O
al	O
.,	O
2013	O
;	O
Bidinosti	O
et	O
al	O
.,	O
2016	O
;	O
Wang	O
et	O
al	O
.,	O
2016	O
;	O
Vicidomini	O
et	O
al	O
.,	O
2017	O
).	O

Therefore	O
,	O
it	O
is	O
conceivable	O
that	O
such	O
signaling	O
pathways	O
might	O
also	O
be	O
altered	O
especially	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
which	O
could	O
potentially	O
provide	O
an	O
insight	O
into	O
the	O
molecular	O
pathophysiology	O
underlying	O
the	O
striatal	O
dysfunction	O
in	O
manic	O
-	O
like	O
behaviors	O
.	O

To	O
address	O
this	O
issue	O
,	O
in	O
this	O
study	O
,	O
we	O
performed	O
a	O
transcriptome	O
(	O
RNA	O
sequencing	O
)	O
analysis	O
on	O
the	O
striatal	O
tissue	O
of	O
adult	O
WT	O
and	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
the	O
results	O
of	O
which	O
suggested	O
mTORC1	B-GP
signaling	O
as	O
the	O
primary	O
molecular	O
signature	O
affected	O
by	O
Shank3	B-GP
overexpression	O
.	O

Based	O
on	O
the	O
transcriptome	O
analysis	O
,	O
we	O
examined	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
and	O
found	O
that	O
it	O
was	O
decreased	O
compared	O
to	O
that	O
in	O
WT	O
mice	B-OG
.	O

To	O
understand	O
the	O
potential	O
underlying	O
mechanisms	O
,	O
we	O
re	O
-	O
analyzed	O
the	O
previously	O
reported	O
protein	O
interactome	O
data	O
,	O
which	O
revealed	O
that	O
94	O
interactors	O
were	O
shared	O
between	O
Shank3	B-GP
and	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
(	O
TSC1	B-GP
,	O
TSC2	B-GP
and	O
Rhes	B-GP
).	O

Moreover	O
,	O
we	O
found	O
that	O
several	O
of	O
the	O
94	O
common	O
interactors	O
were	O
involved	O
in	O
regulating	O
actin	B-GP
filaments	O
(	O
F	B-GP
-	I-GP
actin	I-GP
),	O
the	O
amount	O
of	O
which	O
was	O
increased	O
in	O
the	O
dorsal	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

By	O
performing	O
a	O
comparison	O
with	O
the	O
disease	O
-	O
associated	O
gene	O
sets	O
,	O
we	O
found	O
that	O
these	O
94	O
common	O
interactors	O
were	O
significantly	O
associated	O
with	O
BD	B-DS
and	O
SCZ	B-DS
,	O
but	O
not	O
ASDs	B-DS
.	O

Altogether	O
,	O
our	O
results	O
suggest	O
a	O
protein	O
interaction	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
certain	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
that	O
might	O
contribute	O
to	O
the	O
abnormal	O
striatal	O
mTORC1	B-GP
activity	O
and	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
manic	O
-	O
like	O
behaviors	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Materials	O
and	O
Methods	O

Mice	B-OG

The	O
enhanced	B-GP
green	I-GP
fluorescent	I-GP
protein	I-GP
(	O
EGFP	B-GP
)-	O
Shank3	B-GP
TG	O
mice	B-OG
used	O
in	O
this	O
study	O
have	O
been	O
described	O
previously	O
(	O
Han	O
et	O
al	O
.,	O
2013b	O
;	O
Lee	O
B	O
.	O
et	O
al	O
.,	O
2017	O
;	O
Lee	O
Y	O
.	O
et	O
al	O
.,	O
2017	O
).	O

The	O
WT	O
and	O
Shank3	B-GP
TG	O
mice	B-OG
were	O
bred	O
and	O
maintained	O
on	O
a	O
C57BL	O
/	O
6J	O
background	O
according	O
to	O
the	O
Korea	O
University	O
College	O
of	O
Medicine	O
Research	O
Requirements	O
,	O
and	O
all	O
procedures	O
were	O
approved	O
by	O
the	O
Committees	O
on	O
Animal	O
Research	O
at	O
Korea	O
University	O
College	O
of	O
Medicine	O
(	O
KOREA	O
-	O
2016	O
-	O
0096	O
).	O

The	O
mice	B-OG
were	O
fed	O
ad	O
libitum	O
and	O
housed	O
under	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
.	O

RNA	O
Sequencing	O
and	O
Analysis	O

The	O
mice	B-OG
(	O
12	O
-	O
week	O
-	O
old	O
male	O
WT	O
and	O
Shank3	B-GP
TG	O
,	O
three	O
mice	B-OG
per	O
genotype	O
)	O
were	O
deeply	O
anesthetized	O
with	O
isoflurane	O
and	O
decapitated	O
.	O

The	O
striatum	O
was	O
dissected	O
from	O
each	O
brain	O
using	O
a	O
brain	O
matrix	O
,	O
immediately	O
placed	O
in	O
RNAlater	O
solution	O
(	O
Ambion	O
),	O
and	O
stored	O
at	O
4	O
°	O
C	O
overnight	O
.	O

RNA	O
extraction	O
,	O
library	O
preparation	O
,	O
cluster	O
generation	O
,	O
and	O
sequencing	O
were	O
performed	O
by	O
Macrogen	O
Inc	O
.	O

(	O
Seoul	O
,	O
Korea	O
).	O

RNA	O
samples	O
for	O
sequencing	O
were	O
prepared	O
using	O
a	O
TruSeq	O
RNA	O
Sample	O
Prep	O
Kit	O
v2	O
(	O
Illumina	O
)	O
according	O
to	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

An	O
Illumina	O
’	O
s	O
HiSeq	O
2000	O
was	O
used	O
for	O
sequencing	O
to	O
generate	O
101	O
-	O
bp	O
paired	O
-	O
end	O
reads	O
(	O
Supplementary	O
Table	O
S1	O
).	O

Raw	O
data	O
were	O
submitted	O
to	O
the	O
Gene	O
Expression	O
Omnibus	O
(	O
GEO	O
)	O
repository	O
with	O
accession	O
GSE97544	O
.	O

Pre	O
-	O
processing	O
of	O
raw	O
reads	O
was	O
carried	O
out	O
using	O
Trimmomatic	O
(	O
Bolger	O
et	O
al	O
.,	O
2014	O
)	O
(	O
version	O
0	O
.	O
35	O
,	O
options	O
:	O
LEADING	O
:	O
3	O
TRAILING	O
:	O
3	O
MAXINFO	O
:	O
80	O
:	O
0	O
.	O
4	O
MINLEN	O
:	O
36	O
),	O
and	O
the	O
trimmed	O
reads	O
were	O
mapped	O
to	O
the	O
Mus	B-OG
musculus	I-OG
genome	O
(	O
GRCm38	O
)	O
using	O
TopHat2	O
(	O
Kim	O
D	O
.	O
et	O
al	O
.,	O
2013	O
;	O
version	O
2	O
.	O
1	O
.	O
0	O
,	O
default	O
options	O
).	O

The	O
gene	O
-	O
level	O
read	O
counts	O
were	O
calculated	O
from	O
the	O
aligned	O
reads	O
using	O
HTSeq	O
Python	O
package	O
(	O
Anders	O
et	O
al	O
.,	O
2015	O
).	O

Differential	O
gene	O
expression	O
analysis	O
was	O
performed	O
using	O
DEseq2	O
package	O
in	O
R	O
/	O
Bioconductor	O
(	O
Love	O
et	O
al	O
.,	O
2014	O
).	O

Normalized	O
read	O
counts	O
were	O
computed	O
by	O
dividing	O
the	O
raw	O
read	O
counts	O
by	O
size	O
factors	O
and	O
fitted	O
to	O
a	O
negative	O
binomial	O
distribution	O
.	O

The	O
P	O
values	O
were	O
first	O
corrected	O
by	O
applying	O
an	O
empirical	O
estimation	O
of	O
the	O
null	O
distribution	O
using	O
the	O
R	O
fdrtool	O
(	O
v	O
.	O
1	O
.	O
2	O
.	O
15	O
)	O
package	O
and	O
then	O
adjusted	O
for	O
multiple	O
testing	O
with	O
the	O
Benjamini	O
–	O
Hochberg	O
correction	O
.	O

Genes	O
with	O
an	O
adjusted	O
P	O
value	O
of	O
less	O
than	O
0	O
.	O
05	O
were	O
considered	O
as	O
differentially	O
expressed	O
.	O

Gene	O
Set	O
Enrichment	O
Analysis	O
(	O
GSEA1	O
;	O
Subramanian	O
et	O
al	O
.,	O
2005	O
)	O
was	O
used	O
to	O
determine	O
whether	O
a	O
priori	O
-	O
defined	O
gene	O
sets	O
would	O
show	O
statistically	O
significant	O
differences	O
in	O
expression	O
between	O
Shank3	B-GP
TG	O
and	O
WT	O
mice	B-OG
.	O

Enrichment	O
analysis	O
was	O
performed	O
using	O
GSEAPreranked	O
(	O
gsea2	O
-	O
2	O
.	O
2	O
.	O
2	O
.	O
jar	O
)	O
module	O
on	O
gene	O
set	O
collections	O
H	O
(	O
Hallmark	O
gene	O
sets	O
;	O
50	O
gene	O
sets	O
)	O
downloaded	O
from	O
Molecular	O
Signature	O
Database	O
(	O
MSigDB	O
)	O
v5	O
.	O
12	O
.	O

Additionally	O
,	O
GSEA	O
analysis	O
was	O
performed	O
by	O
using	O
the	O
sets	O
of	O
genes	O
associated	O
with	O
psychiatric	B-DS
disease	I-DS
from	O
the	O
Psychiatric	B-DS
disorders	I-DS
Gene	O
association	O
NETwork	O
(	O
PsyGeNET	O
)	O
database	O
(	O
last	O
update	O
:	O
Sept	O
.,	O
2016	O
;	O
Gutierrez	O
-	O
Sacristan	O
et	O
al	O
.,	O
2015	O
).	O

GSEAPreranked	O
was	O
applied	O
using	O
the	O
list	O
of	O
all	O
genes	O
expressed	O
,	O
ranked	O
by	O
the	O
fold	O
change	O
and	O
multiplied	O
by	O
the	O
inverse	O
of	O
the	O
P	O
value	O
with	O
recommended	O
default	O
settings	O
(	O
1000	O
permutations	O
and	O
a	O
classic	O
scoring	O
scheme	O
).	O

The	O
False	O
Discovery	O
Rate	O
(	O
FDR	O
)	O
was	O
estimated	O
to	O
control	O
the	O
false	O
positive	O
finding	O
of	O
a	O
given	O
Normalized	O
Enrichment	O
Score	O
(	O
NES	O
)	O
by	O
comparing	O
the	O
tails	O
of	O
the	O
observed	O
and	O
null	O
distributions	O
derived	O
from	O
1000	O
gene	O
set	O
permutations	O
.	O

The	O
gene	O
sets	O
with	O
an	O
FDR	O
of	O
less	O
than	O
0	O
.	O
05	O
were	O
considered	O
as	O
significantly	O
enriched	O
.	O

Construction	O
of	O
Interactome	O
Network	O

To	O
build	O
an	O
interaction	O
network	O
,	O
the	O
sets	O
of	O
Shank3	B-GP
(	O
Han	O
et	O
al	O
.,	O
2013b	O
),	O
TSC1	B-GP
/	O
TSC2	B-GP
(	O
Sakai	O
et	O
al	O
.,	O
2011	O
)	O
and	O
Rhes	B-GP
(	O
Shahani	O
et	O
al	O
.,	O
2016	O
)	O
interactomes	O
were	O
adopted	O
.	O

The	O
network	O
graphics	O
were	O
generated	O
using	O
Cytoscape	O
(	O
Shannon	O
et	O
al	O
.,	O
2003	O
).	O

To	O
simplify	O
the	O
network	O
,	O
orphan	O
nodes	O
,	O
defined	O
as	O
the	O
nodes	O
connecting	O
with	O
only	O
one	O
of	O
the	O
hub	O
proteins	O
(	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
),	O
were	O
excluded	O
from	O
the	O
graphics	O
.	O

Gene	O
Ontology	O
(	O
GO	O
)	O
and	O
Kyoto	O
Encyclopedia	O
of	O
Genes	O
and	O
Genomes	O
(	O
KEGG	O
)	O
Pathway	O
Analysis	O

The	O
Gene	O
Ontology	O
(	O
GO	O
)	O
and	O
Kyoto	O
Encyclopedia	O
of	O
Genes	O
and	O
Genomes	O
(	O
KEGG	O
)	O
pathway	O
analyses	O
were	O
performed	O
using	O
DAVID	O
software	O
(	O
version	O
6	O
.	O
8	O
;	O
Huang	O
Da	O
et	O
al	O
.,	O
2009	O
).	O

The	O
set	O
of	O
94	O
genes	O
from	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
was	O
tested	O
against	O
a	O
customized	O
background	O
of	O
the	O
entire	O
mouse	B-OG
genome	O
.	O

Mouse	B-OG
gene	O
names	O
were	O
converted	O
to	O
human	B-OG
homologs	O
using	O
the	O
Mouse	B-OG
Genome	O
Informatics	O
(	O
MGI	O
)	O
database3	O
.	O

Disease	O
Association	O
Analysis	O

Gene	O
-	O
disease	O
association	O
data	O
were	O
retrieved	O
from	O
the	O
PsyGeNET	O
(	O
Gutierrez	O
-	O
Sacristan	O
et	O
al	O
.,	O
2015	O
)	O
and	O
Disease	O
gene	O
association	O
NETwork	O
(	O
DisGeNET	O
)	O
databases	O
(	O
Piñero	O
et	O
al	O
.,	O
2015	O
;	O
last	O
update	O
:	O
Sept	O
.,	O
2016	O
).	O

PsyGeNET	O
database	O
contains	O
information	O
relevant	O
to	O
psychiatric	B-DS
diseases	I-DS
and	O
their	O
associated	O
genes	O
integrated	O
from	O
the	O
DisGeNET	O
(	O
Piñero	O
et	O
al	O
.,	O
2017	O
)	O
database	O
,	O
and	O
data	O
extracted	O
from	O
the	O
literature	O
by	O
text	O
mining	O
,	O
and	O
further	O
curated	O
by	O
the	O
experts	O
in	O
the	O
domain	O
.	O

Additionally	O
,	O
the	O
genes	O
associated	O
with	O
the	O
risk	O
for	O
ASD	B-DS
were	O
obtained	O
from	O
the	O
Simons	O
Foundation	O
Autism	B-DS
Research	O
Initiative	O
(	O
SFARI	O
)	O
database	O
(	O
syndromic	O
and	O
category	O
3	O
or	O
above4	O
).	O

The	O
enrichment	O
of	O
disease	O
-	O
associated	O
genes	O
was	O
tested	O
using	O
the	O
hypergeometric	O
distribution	O
test	O
.	O

Hypergeometric	O
P	O
values	O
were	O
calculated	O
using	O
the	O
phyper	O
(	O
q	O
:	O
overlapped	O
genes	O
-	O
1	O
,	O
m	O
:	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
,	O
n	O
:	O
protein	O
-	O
coding	O
genes	O
in	O
The	O
HUGO	O
Gene	O
Nomenclature	O
Committee	O
(	O
HGNC	O
)—	O
m	O
,	O
k	O
:	O
disease	O
associated	O
genes	O
)	O
function	O
in	O
R	O
package	O
,	O
and	O
were	O
adjusted	O
for	O
multiple	O
testing	O
with	O
the	O
Benjamini	O
and	O
Hochberg	O
test	O
,	O
as	O
implemented	O
in	O
the	O
Bioconductor	O
’	O
s	O
q	O
value	O
package	O
.	O

Diseases	O
with	O
adjusted	O
P	O
values	O
of	O
less	O
than	O
0	O
.	O
05	O
were	O
considered	O
as	O
statistically	O
significantly	O
enriched	O
.	O

RNA	O
Purification	O
and	O
qRT	O
-	O
PCR	O

Real	O
-	O
time	O
quantitative	O
reverse	O
transcription	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
was	O
performed	O
as	O
described	O
previously	O
(	O
Han	O
et	O
al	O
.,	O
2013a	O
;	O
Kim	O
et	O
al	O
.,	O
2016	O
;	O
Lee	O
B	O
.	O
et	O
al	O
.,	O
2017	O
).	O

Briefly	O
,	O
total	O
RNA	O
was	O
extracted	O
from	O
the	O
striatum	O
of	O
12	O
-	O
week	O
-	O
old	O
mice	B-OG
using	O
a	O
miRNeasy	O
minikit	O
(	O
Qiagen	O
)	O
according	O
to	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Two	O
micrograms	O
of	O
total	O
RNA	O
were	O
used	O
for	O
cDNA	O
synthesis	O
using	O
iScriptTM	O
cDNA	O
Synthesis	O
Kit	O
(	O
Bio	O
-	O
Rad	O
).	O

Target	O
mRNAs	O
were	O
detected	O
and	O
quantified	O
by	O
a	O
real	O
-	O
time	O
PCR	O
instrument	O
(	O
CFX96	O
Touch	O
,	O
Bio	O
-	O
Rad	O
)	O
using	O
SYBR	O
Green	O
master	O
mix	O
(	O
Bio	O
-	O
Rad	O
).	O

The	O
results	O
were	O
analyzed	O
using	O
the	O
comparative	O
Ct	O
method	O
normalized	O
against	O
the	O
housekeeping	O
gene	O
Gapdh	B-GP
.	O

The	O
primer	O
sequences	O
for	O
real	O
-	O
time	O
PCR	O
are	O
as	O
follows	O
:	O
Mouse	B-OG
Shank3	B-GP
forward	O
5	O
′	O
TGGTTGGCAAGAGATCCAT	O
3	O
′,	O
reverse	O
5	O
′	O
TTGGCCCCATAGAACAAAAG	O
3	O
′	O
Mouse	B-OG
Gpr85	B-GP
forward	O
5	O
′	O
ATGCAGCCGACAACATTTTGC	O
3	O
′,	O
reverse	O
5	O
′	O
CAGGTGGAGCCATTTTTGACA	O
3	O
′	O
Mouse	B-OG
Clic6	B-GP
forward	O
5	O
′	O
CTCTGGGTTAGACTCTCAGGG	O
3	O
′,	O
reverse	O
5	O
′	O
GGTGCCTCTGTGTCCATGTT	O
3	O
′	O
Mouse	B-OG
Plk5	B-GP
forward	O
5	O
′	O
CGGCACCCTTGTCAGAGATG	O
3	O
′,	O
reverse	O
5	O
′	O
TGGGGGAAAGGCAAACACAG	O
3	O
′	O
Mouse	B-OG
Gapdh	B-GP
forward	O
5	O
′	O
GGCATTGCTCTCAATGACAA	O
3	O
′,	O
reverse	O
5	O
′	O
CCCTGTTGCTGTAGCCGTAT	O
3	O
′	O

Biochemistry	O
and	O
Antibodies	O
for	O
Western	O
Blotting	O

Whole	O
lysates	O
of	O
the	O
mouse	B-OG
brain	O
were	O
prepared	O
as	O
described	O
previously	O
(	O
Han	O
et	O
al	O
.,	O
2009	O
,	O
2015	O
).	O

Briefly	O
,	O
the	O
striatum	O
and	O
hippocampus	O
of	O
12	O
-	O
week	O
-	O
old	O
mice	B-OG
were	O
homogenized	O
in	O
RIPA	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
150	O
mM	O
NaCl	O
,	O
0	O
.	O
1	O
%	O
SDS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
0	O
.	O
5	O
%	O
sodium	O
deoxycholate	O
)	O
with	O
freshly	O
added	O
protease	B-GP
and	O
phosphatase	B-GP
inhibitors	O
(	O
Roche	O
).	O

Protein	O
concentration	O
was	O
measured	O
using	O
Bradford	O
Protein	O
Assay	O
(	O
Bio	O
-	O
Rad	O
).	O

Brain	O
lysates	O
were	O
heated	O
in	O
1x	O
NuPAGE	O
LDS	O
sample	O
buffer	O
(	O
Invitrogen	O
)	O
containing	O
a	O
1x	O
NuPAGE	O
reducing	O
agent	O
(	O
Invitrogen	O
).	O

From	O
each	O
sample	O
,	O
10	O
~	O
20	O
μg	O
of	O
proteins	O
were	O
loaded	O
for	O
Western	O
blotting	O
.	O

Immunoprecipitation	O
(	O
IP	O
)	O
was	O
performed	O
as	O
described	O
previously	O
(	O
Han	O
et	O
al	O
.,	O
2013b	O
;	O
Lee	O
Y	O
.	O
et	O
al	O
.,	O
2017	O
).	O

The	O
GFP	B-GP
-	O
Trap	O
beads	O
(	O
ChromoTek	O
)	O
were	O
used	O
to	O
pull	O
down	O
EGFP	B-GP
-	O
Shank3	B-GP
proteins	O
and	O
their	O
interactors	O
.	O

The	O
antibodies	O
used	O
for	O
Western	O
blotting	O
were	O
Gapdh	B-GP
(	O
Cell	O
Signaling	O
,	O
#	O
2118	O
),	O
GFP	B-GP
(	O
NeuroMAb	O
,	O
#	O
75	O
-	O
131	O
),	O
Homer1b	B-GP
/	I-GP
c	I-GP
(	O
Santa	O
Cruz	O
,	O
sc	O
-	O
20807	O
),	O
Rhes	B-GP
(	O
Millipore	O
,	O
ABN31	O
),	O
Shank3	B-GP
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
sc	O
-	O
30193	O
),	O
phospho	O
-	O
mTOR	B-GP
(	O
S2448	O
,	O
Cell	O
Signaling	O
,	O
#	O
2971	O
),	O
mTOR	B-GP
(	O
Cell	O
Signaling	O
,	O
#	O
2983	O
),	O
and	O
WAVE1	B-GP
(	O
NeuroMab	O
,	O
75	O
-	O
048	O
).	O

Western	O
blot	O
images	O
were	O
acquired	O
by	O
ChemiDoc	O
Touch	O
Imaging	O
System	O
(	O
Bio	O
-	O
Rad	O
)	O
and	O
quantified	O
using	O
ImageJ	O
software	O
.	O

Immunohistochemistry	O
and	O
Image	O
Analysis	O

For	O
each	O
immunohistochemistry	O
(	O
IHC	O
)	O
experiment	O
,	O
5	O
–	O
7	O
pairs	O
of	O
12	O
-	O
week	O
-	O
old	O
WT	O
and	O
Shank3	B-GP
TG	O
mice	B-OG
from	O
at	O
least	O
three	O
different	O
litters	O
were	O
used	O
.	O

The	O
mice	B-OG
were	O
deeply	O
anesthetized	O
with	O
isoflurane	O
and	O
transcardially	O
perfused	O
with	O
heparinized	O
(	O
20	O
units	O
/	O
ml	O
)	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
followed	O
by	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
in	O
PBS	O
.	O

Brains	O
were	O
extracted	O
and	O
post	O
-	O
fixed	O
in	O
4	O
%	O
PFA	O
overnight	O
.	O

After	O
post	O
-	O
fixation	O
,	O
the	O
brains	O
were	O
washed	O
with	O
PBS	O
and	O
cryoprotected	O
with	O
30	O
%	O
sucrose	O
in	O
PBS	O
for	O
48	O
h	O
.	O

Brains	O
were	O
frozen	O
in	O
O	O
.	O
C	O
.	O
T	O
compound	O
(	O
SAKURA	O
Tissue	O
-	O
Tek	O
,	O
4583	O
)	O
and	O
sectioned	O
(	O
60	O
μm	O
)	O
using	O
a	O
cryostat	O
microtome	O
(	O
Leica	O
,	O
CM3050S	O
).	O

For	O
each	O
staining	O
set	O
,	O
two	O
sections	O
were	O
randomly	O
selected	O
from	O
each	O
mouse	B-OG
at	O
a	O
similar	O
anterior	O
posterior	O
level	O
.	O

The	O
following	O
antibodies	O
were	O
used	O
:	O
GFP	B-GP
(	O
Abcam	O
,	O
ab290	O
,	O
1	O
:	O
500	O
),	O
neuronal	B-GP
nuclei	I-GP
(	O
NeuN	B-GP
;	O
Millipore	O
,	O
MAB377	O
,	O
1	O
:	O
1000	O
),	O
rhodamine	O
phalloidin	O
(	O
Molecular	O
Probes	O
,	O
R415	O
,	O
1	O
unit	O
/	O
200	O
μl	O
),	O
and	O
Alexa	O
Fluor	O
-	O
conjugated	O
secondary	O
antibodies	O
(	O
Jackson	O
Immunoresearch	O
,	O
111	O
-	O
585	O
-	O
003	O
and	O
115	O
-	O
585	O
-	O
003	O
,	O
1	O
:	O
500	O
).	O

Confocal	O
microscopy	O
(	O
Zeiss	O
,	O
LSM800	O
)	O
was	O
used	O
to	O
acquire	O
images	O
(	O
10	O
×	O
objective	O
and	O
0	O
.	O
6	O
×	O
digital	O
zoom	O
)	O
of	O
the	O
striatum	O
(	O
Bregma	O
0	O
.	O
13	O
–	O
1	O
.	O
7	O
)	O
from	O
coronal	O
sections	O
.	O

Whole	O
regions	O
were	O
obtained	O
by	O
tile	O
scanning	O
and	O
each	O
frame	O
was	O
taken	O
in	O
Z	O
-	O
stacks	O
of	O
5	O
–	O
10	O
slices	O
(	O
in	O
total	O
45	O
–	O
55	O
μm	O
thickness	O
).	O

Tiled	O
Z	O
-	O
projection	O
images	O
were	O
aligned	O
and	O
converted	O
into	O
a	O
single	O
flattened	O
image	O
using	O
ZEN	O
software	O
from	O
Zeiss	O
.	O

From	O
each	O
tiled	O
image	O
,	O
randomly	O
selected	O
two	O
regions	O
of	O
interests	O
(	O
ROIs	O
)	O
were	O
analyzed	O
for	O
the	O
dorsolateral	O
(	O
DL	O
),	O
dorsomedial	O
(	O
DM	O
),	O
and	O
dorsoventral	O
(	O
DV	O
;	O
ventral	O
part	O
of	O
the	O
dorsal	O
striatum	O
)	O
striatum	O
using	O
ImageJ	O
software	O
.	O

All	O
quantifications	O
were	O
carried	O
out	O
by	O
operators	O
blinded	O
to	O
the	O
genotype	O
.	O

Quantification	O
and	O
Statistical	O
Analysis	O

Values	O
from	O
at	O
least	O
three	O
independent	O
experiments	O
using	O
were	O
used	O
for	O
quantification	O
and	O
statistical	O
analysis	O
.	O

This	O
means	O
that	O
we	O
performed	O
at	O
least	O
three	O
independent	O
technical	O
experiments	O
,	O
and	O
we	O
used	O
different	O
biological	O
samples	O
for	O
each	O
technical	O
experiment	O
.	O
P	O
values	O
were	O
calculated	O
by	O
two	O
-	O
tailed	O
unpaired	O
Student	O
’	O
s	O
t	O
-	O
test	O
unless	O
otherwise	O
specified	O
,	O
using	O
GraphPad	O
Prism	O
6	O
software	O
.	O

All	O
data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
;	O
**	O
P	O
<	O
0	O
.	O
01	O
;	O
***	O
P	O
<	O
0	O
.	O
001	O
.	O

Results	O

Striatal	O
Transcriptome	O
Analysis	O
of	O
Shank3	B-GP
TG	O
Mice	B-OG

To	O
identify	O
which	O
signaling	O
pathways	O
were	O
altered	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
we	O
performed	O
transcriptome	O
(	O
RNA	O
sequencing	O
,	O
RNA	O
-	O
seq	O
)	O
analysis	O
with	O
the	O
striatal	O
tissue	O
from	O
12	O
-	O
week	O
-	O
old	O
WT	O
and	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Although	O
most	O
Shank3	B-GP
proteins	O
function	O
at	O
the	O
excitatory	O
postsynapse	O
,	O
and	O
thus	O
,	O
are	O
less	O
likely	O
to	O
directly	O
regulate	O
broad	O
gene	O
transcription	O
,	O
we	O
reasoned	O
that	O
this	O
unbiased	O
approach	O
might	O
(	O
indirectly	O
)	O
reflect	O
major	O
signaling	O
pathways	O
affected	O
by	O
mild	O
Shank3	B-GP
overexpression	O
.	O

As	O
expected	O
,	O
the	O
overall	O
changes	O
in	O
gene	O
expression	O
were	O
mild	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
compared	O
to	O
that	O
of	O
WT	O
mice	B-OG
(	O
Figure	O
1A	O
and	O
Supplementary	O
Table	O
S2	O
).	O

After	O
applying	O
adjusted	O
P	O
values	O
(<	O
0	O
.	O
05	O
,	O
Benjamini	O
–	O
Hochberg	O
correction	O
),	O
we	O
could	O
identify	O
22	O
up	O
-	O
regulated	O
and	O
17	O
down	O
-	O
regulated	O
genes	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
(	O
Supplementary	O
Table	O
S3	O
);	O
Shank3	B-GP
(	O
1	O
.	O
77	O
fold	O
),	O
G	B-GP
protein	I-GP
-	I-GP
coupled	I-GP
receptor	I-GP
85	I-GP
(	O
Gpr85	B-GP
,	O
1	O
.	O
23	O
fold	O
),	O
and	O
Chloride	B-GP
intracellular	I-GP
channel	I-GP
6	I-GP
(	O
Clic6	B-GP
,	O
1	O
.	O
16	O
fold	O
)	O
were	O
the	O
top	O
three	O
up	O
-	O
regulated	O
genes	O
,	O
while	O
Polo	B-GP
like	I-GP
kinase	I-GP
5	I-GP
(	O
Plk5	B-GP
,	O
−	O
1	O
.	O
28	O
fold	O
),	O
Immunoglobulin	B-GP
-	I-GP
like	I-GP
and	I-GP
fibronectin	I-GP
type	I-GP
III	I-GP
domain	I-GP
containing	I-GP
1	I-GP
(	O
Igfn1	B-GP
,	O
−	O
1	O
.	O
19	O
fold	O
),	O
and	O
Inhibitor	B-GP
of	I-GP
DNA	I-GP
binding	I-GP
3	I-GP
(	O
Id3	B-GP
,	O
−	O
1	O
.	O
16	O
fold	O
)	O
were	O
the	O
top	O
three	O
down	O
-	O
regulated	O
genes	O
(	O
Figure	O
1B	O
),	O
some	O
of	O
which	O
were	O
validated	O
by	O
qRT	O
-	O
PCR	O
(	O
Supplementary	O
Table	O
S3	O
and	O
Supplementary	O
Figure	O
S1	O
).	O

RNA	O
-	O
seq	O
analyses	O
and	O
measurements	O
of	O
mammalian	B-GP
target	I-GP
of	I-GP
rapamycin	I-GP
complex	I-GP
1	I-GP
(	O
mTORC1	B-GP
)	O
activity	O
in	O
the	O
SH3	B-GP
and	I-GP
multiple	I-GP
ankyrin	I-GP
repeat	I-GP
domains	I-GP
3	I-GP
(	O
Shank3	B-GP
)	O
transgenic	O
(	O
TG	O
)	O
striatum	O
.	O
(	O
A	O
)	O
Volcano	O
plot	O
for	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Differentially	O
expressed	O
genes	O
(	O
DEGs	O
),	O
defined	O
by	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
<	O
0	O
.	O
05	O
,	O
are	O
shown	O
as	O
blue	O
(	O
down	O
-	O
regulated	O
)	O
and	O
red	O
(	O
up	O
-	O
regulated	O
)	O
circles	O
.	O

FC	O
,	O
fold	O
change	O
.	O

The	O
complete	O
lists	O
of	O
RNA	O
-	O
seq	O
analysis	O
and	O
DEGs	O
are	O
provided	O
in	O
the	O
Supplementary	O
Tables	O
S2	O
,	O
S3	O
.	O
(	O
B	O
)	O
List	O
of	O
top	O
10	O
up	O
-	O
regulated	O
and	O
down	O
-	O
regulated	O
DEGs	O
(	O
based	O
on	O
the	O
fold	O
changes	O
)	O
from	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O
(	O
C	O
)	O
The	O
bar	O
graph	O
shows	O
normalized	O
enrichment	O
scores	O
(	O
NES	O
)	O
of	O
gene	O
set	O
enrichment	O
analysis	O
(	O
GSEA	O
)	O
on	O
the	O
Hallmark	O
gene	O
sets	O
for	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Asterisks	O
indicate	O
the	O
gene	O
sets	O
with	O
an	O
FDR	O
of	O
less	O
than	O
0	O
.	O
05	O
.	O

The	O
complete	O
list	O
that	O
contains	O
the	O
results	O
of	O
GSEA	O
analysis	O
is	O
provided	O
in	O
Supplementary	O
Table	O
S4	O
.	O
(	O
D	O
)	O
The	O
enrichment	O
plot	O
of	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
on	O
the	O
mTORC1	B-GP
signaling	O
gene	O
set	O
.	O

The	O
complete	O
list	O
of	O
mTORC1	B-GP
signaling	O
genes	O
within	O
the	O
Shank3	B-GP
TG	O
RNA	O
-	O
seq	O
analysis	O
is	O
provided	O
in	O
Supplementary	O
Table	O
S5	O
.	O
(	O
E	O
)	O
Representative	O
Western	O
blot	O
images	O
and	O
quantifications	O
show	O
that	O
mTORC1	B-GP
activity	O
measured	O
by	O
mTOR	B-GP
S2448	O
phosphorylation	O
is	O
decreased	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

The	O
total	O
mTOR	B-GP
expression	O
level	O
is	O
not	O
significantly	O
different	O
between	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
Shank3	B-GP
TG	O
striatum	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
10	O
animals	B-OG
per	O
genotype	O
;	O
**	O
P	O
<	O
0	O
.	O
01	O
,	O
unpaired	O
two	O
-	O
tailed	O
Student	O
’	O
s	O
t	O
-	O
test	O
).	O
(	O
F	O
)	O
Normal	O
mTORC1	B-GP
activity	O
and	O
total	O
mTOR	B-GP
protein	O
levels	O
in	O
the	O
hippocampus	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
n	O
=	O
6	O
animals	B-OG
per	O
genotype	O
).	O

Next	O
,	O
we	O
performed	O
GSEA	O
to	O
identify	O
biologically	O
meaningful	O
signatures	O
in	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
striatal	O
RNA	O
-	O
seq	O
data	O
.	O

We	O
found	O
that	O
several	O
biological	O
pathways	O
including	O
“	O
mTORC1	B-GP
signaling	O
”,	O
“	O
protein	O
secretion	O
”,	O
“	O
Myc	B-GP
targets	O
V1	O
”,	O
“	O
unfolded	O
protein	O
response	O
(	O
UPR	O
)”,	O
and	O
“	O
oxidative	O
phosphorylation	O
”	O
were	O
represented	O
by	O
the	O
genes	O
up	O
-	O
regulated	O
in	O
Shank3	B-GP
TG	O
striatum	O
(	O
Figure	O
1C	O
and	O
Supplementary	O
Table	O
S4	O
).	O

Among	O
them	O
,	O
“	O
mTORC1	B-GP
signaling	O
”	O
was	O
the	O
top	O
ranked	O
pathway	O
based	O
on	O
the	O
NES	O
(	O
Figures	O
1C	O
,	O
D	O
and	O
Supplementary	O
Tables	O
S4	O
,	O
S5	O
).	O

Moreover	O
,	O
protein	O
secretion	O
,	O
UPR	O
,	O
and	O
oxidative	O
phosphorylation	O
are	O
the	O
cellular	O
processes	O
tightly	O
coupled	O
with	O
mTORC1	B-GP
signaling	O
(	O
Narita	O
et	O
al	O
.,	O
2011	O
;	O
Appenzeller	O
-	O
Herzog	O
and	O
Hall	O
,	O
2012	O
;	O
Morita	O
et	O
al	O
.,	O
2013	O
),	O
which	O
further	O
supports	O
the	O
hypothesis	O
that	O
mTORC1	B-GP
signaling	O
may	O
be	O
the	O
primary	O
molecular	O
signature	O
in	O
the	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
striatum	O
.	O

In	O
contrast	O
to	O
the	O
up	O
-	O
regulated	O
genes	O
,	O
the	O
genes	O
down	O
-	O
regulated	O
in	O
Shank3	B-GP
TG	O
striatum	O
depicted	O
no	O
significant	O
enrichment	O
in	O
any	O
specific	O
biological	O
pathways	O
(	O
Figure	O
1C	O
and	O
Supplementary	O
Table	O
S4	O
).	O

Based	O
on	O
the	O
results	O
from	O
GSEA	O
,	O
we	O
directly	O
investigated	O
the	O
striatal	O
mTORC1	B-GP
activity	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
by	O
measuring	O
the	O
phosphorylation	O
level	O
of	O
mTOR	B-GP
S2448	O
residue	O
.	O

The	O
phosphorylation	O
of	O
mTOR	B-GP
S2448	O
is	O
predominantly	O
associated	O
with	O
mTORC1	B-GP
(	O
Copp	O
et	O
al	O
.,	O
2009	O
),	O
and	O
reflects	O
its	O
activation	O
as	O
S6	B-GP
kinase	I-GP
,	O
a	O
downstream	O
target	O
of	O
mTORC1	B-GP
,	O
phosphorylates	O
the	O
residue	O
in	O
a	O
feedback	O
loop	O
(	O
Chiang	O
and	O
Abraham	O
,	O
2005	O
).	O

We	O
found	O
that	O
the	O
phosphorylation	O
level	O
of	O
mTOR	B-GP
S2448	O
normalized	O
to	O
total	O
mTOR	B-GP
expression	O
was	O
significantly	O
decreased	O
by	O
approximately	O
15	O
%	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
compared	O
to	O
that	O
of	O
WT	O
mice	B-OG
(	O
Figure	O
1E	O
).	O

The	O
total	O
expression	O
level	O
of	O
mTOR	B-GP
protein	O
was	O
not	O
significantly	O
altered	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Figure	O
1E	O
).	O

In	O
contrast	O
to	O
the	O
striatum	O
,	O
neither	O
phospho	O
nor	O
total	O
mTOR	B-GP
protein	O
was	O
altered	O
in	O
the	O
hippocampus	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Figure	O
1F	O
).	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
mild	O
overexpression	O
of	O
Shank3	B-GP
decreases	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Protein	O
Interactome	O
Analysis	O
of	O
Shank3	B-GP
with	O
the	O
Upstream	O
Regulators	O
of	O
mTORC1	B-GP

What	O
could	O
be	O
the	O
mechanism	O
underlying	O
decreased	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
?	O

The	O
serine	B-GP
/	I-GP
threonine	I-GP
kinase	I-GP
PKB	B-GP
/	O
Akt	B-GP
is	O
a	O
key	O
positive	O
upstream	O
regulator	O
of	O
mTORC1	B-GP
that	O
directly	O
phosphorylates	O
and	O
inhibits	O
the	O
TSC1	B-GP
/	O
TSC2	B-GP
complex	O
(	O
Laplante	O
and	O
Sabatini	O
,	O
2012	O
).	O

However	O
,	O
in	O
our	O
original	O
report	O
describing	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
we	O
showed	O
that	O
the	O
activities	O
of	O
PKB	B-GP
/	O
Akt	B-GP
and	O
one	O
of	O
its	O
downstream	O
targets	O
,	O
glycogen	B-GP
synthase	I-GP
kinase	I-GP
3	I-GP
(	O
GSK3	B-GP
),	O
were	O
normal	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

Therefore	O
,	O
we	O
decided	O
to	O
explore	O
alternative	O
targets	O
.	O

We	O
have	O
previously	O
generated	O
a	O
comprehensive	O
Shank3	B-GP
protein	O
interactome	O
consisting	O
of	O
about	O
400	O
proteins	O
,	O
by	O
combining	O
the	O
results	O
from	O
yeast	B-OG
two	O
-	O
hybrid	O
(	O
Y2H	O
)	O
screening	O
(	O
Sakai	O
et	O
al	O
.,	O
2011	O
)	O
and	O
in	O
vivo	O
IP	O
followed	O
by	O
mass	O
spectrometry	O
analysis	O
of	O
the	O
mixed	O
hippocampal	O
and	O
striatal	O
tissue	O
isolated	O
from	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

As	O
Shank3	B-GP
is	O
a	O
core	O
scaffold	B-GP
protein	I-GP
containing	O
multiple	O
protein	O
-	O
protein	O
interaction	O
(	O
PPI	O
)	O
domains	O
,	O
it	O
is	O
possible	O
that	O
the	O
functions	O
of	O
Shank3	B-GP
in	O
neurons	O
could	O
be	O
largely	O
mediated	O
by	O
the	O
interacting	O
proteins	O
(	O
Lee	O
Y	O
.	O
et	O
al	O
.,	O
2017	O
).	O

Notably	O
,	O
Sakai	O
et	O
al	O
.	O
(	O
2011	O
)	O
have	O
previously	O
provided	O
evidence	O
supporting	O
the	O
PPI	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
mTORC1	B-GP
pathway	O
.	O

Specifically	O
,	O
they	O
showed	O
that	O
Shank3	B-GP
and	O
TSC1	B-GP
/	O
TSC2	B-GP
complex	O
are	O
highly	O
connected	O
by	O
many	O
interacting	O
proteins	O
identified	O
by	O
Y2H	O
screening	O
,	O
and	O
that	O
Shank3	B-GP
and	O
TSC1	B-GP
indeed	O
form	O
an	O
in	O
vivo	O
protein	O
complex	O
in	O
the	O
mouse	B-OG
brain	O
.	O

In	O
addition	O
,	O
Shahani	O
et	O
al	O
.	O
(	O
2016	O
)	O
recently	O
published	O
a	O
striatal	O
in	O
vivo	O
protein	O
interactome	O
of	O
Rhes	B-GP
,	O
another	O
upstream	O
regulator	O
of	O
mTORC1	B-GP
,	O
(“	O
Rhesactome	O
”)	O
where	O
Shank3	B-GP
was	O
identified	O
as	O
a	O
Rhes	B-GP
interactor	O
in	O
the	O
striatum	O
.	O

Therefore	O
,	O
we	O
re	O
-	O
analyzed	O
these	O
interactomes	O
(	O
Shank3	B-GP
in	O
vivo	O
+	O
Y2H	O
,	O
TSC1	B-GP
and	O
TSC2	B-GP
Y2H	O
,	O
and	O
Rhes	B-GP
in	O
vivo	O
)	O
side	O
by	O
side	O
to	O
elucidate	O
the	O
identity	O
and	O
the	O
number	O
of	O
proteins	O
interacting	O
both	O
with	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
.	O

Notably	O
,	O
we	O
found	O
an	O
overlap	O
consisting	O
of	O
94	O
proteins	O
(	O
about	O
24	O
%)	O
between	O
the	O
Shank3	B-GP
interactome	O
and	O
either	O
TSC1	B-GP
,	O
TSC2	B-GP
,	O
or	O
Rhes	B-GP
interactome	O
(	O
Figures	O
2A	O
–	O
C	O
and	O
Supplementary	O
Table	O
S6	O
).	O

Among	O
the	O
94	O
proteins	O
,	O
four	O
interactors	O
including	O
Dynactin	B-GP
2	I-GP
(	O
encoded	O
by	O
Dctn2	B-GP
),	O
Ankyrin	B-GP
repeat	I-GP
domain	I-GP
35	I-GP
(	O
Ankrd35	B-GP
),	O
Pleckstrin	B-GP
homology	I-GP
like	I-GP
domain	I-GP
family	I-GP
B	I-GP
member	I-GP
1	I-GP
(	O
Phldb1	B-GP
),	O
and	O
Protein	B-GP
interacting	I-GP
with	I-GP
C	I-GP
kinase	I-GP
1	I-GP
(	O
Pick1	B-GP
)	O
were	O
shared	O
by	O
three	O
proteins	O
(	O
either	O
Shank3	B-GP
/	O
TSC1	B-GP
/	O
TSC2	B-GP
or	O
Shank3	B-GP
/	O
TSC1	B-GP
/	O
Rhes	B-GP
),	O
and	O
one	O
interactor	O
,	O
α	B-GP
-	I-GP
actinin	I-GP
2	I-GP
(	O
encoded	O
by	O
Actn2	B-GP
),	O
was	O
shared	O
by	O
all	O
four	O
proteins	O
(	O
Figures	O
2B	O
,	O
C	O
).	O

Protein	O
interaction	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
.	O
(	O
A	O
)	O
The	O
diagram	O
shows	O
a	O
summary	O
of	O
protein	O
interaction	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
(	O
tuberous	B-GP
sclerosis	I-GP
1	I-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Ras	B-GP
homolog	I-GP
enriched	I-GP
in	I-GP
striatum	I-GP
,	O
Rhes	B-GP
).	O
(	O
B	O
)	O
The	O
Venn	O
diagram	O
shows	O
the	O
number	O
of	O
interactors	O
shared	O
by	O
Shank3	B-GP
,	O
TSC1	B-GP
,	O
TSC2	B-GP
and	O
Rhes	B-GP
proteins	O
.	O

The	O
actin	B-GP
filament	O
bundling	O
protein	O
,	O
α	B-GP
-	I-GP
actinin	I-GP
2	I-GP
(	O
ACTN2	B-GP
),	O
is	O
the	O
only	O
common	O
interactor	O
for	O
all	O
four	O
proteins	O
.	O
(	O
C	O
)	O
The	O
interactome	O
network	O
of	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
.	O

To	O
simplify	O
the	O
network	O
,	O
the	O
orphan	O
nodes	O
,	O
defined	O
as	O
nodes	O
connected	O
with	O
only	O
one	O
of	O
the	O
hub	O
proteins	O
(	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
),	O
are	O
excluded	O
from	O
the	O
graphics	O
.	O

The	O
nodes	O
for	O
94	O
proteins	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
are	O
colored	O
in	O
red	O
.	O

The	O
complete	O
list	O
of	O
interactomes	O
for	O
Shank3	B-GP
,	O
TSC1	B-GP
,	O
TSC2	B-GP
and	O
Rhes	B-GP
is	O
provided	O
in	O
Supplementary	O
Table	O
S6	O
.	O
(	O
D	O
)	O
Gene	O
ontology	O
(	O
GO	O
)	O
and	O
kyoto	O
encyclopedia	O
of	O
genes	O
and	O
genomes	O
(	O
KEGG	O
)	O
pathway	O
analyses	O
of	O
the	O
94	O
proteins	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
.	O

Significant	O
terms	O
(	O
Benjamini	O
adjusted	O
P	O
value	O
<	O
0	O
.	O
05	O
)	O
are	O
in	O
bold	O
red	O
.	O

The	O
complete	O
list	O
of	O
analyses	O
is	O
provided	O
in	O
Supplementary	O
Table	O
S7	O
.	O

To	O
understand	O
the	O
representative	O
biological	O
functions	O
or	O
pathways	O
of	O
the	O
94	O
common	O
interactors	O
,	O
we	O
performed	O
GO	O
and	O
KEGG	O
pathway	O
analysis	O
.	O

We	O
found	O
that	O
terms	O
including	O
“	O
gene	O
expression	O
”	O
in	O
the	O
biological	O
process	O
category	O
,	O
“	O
protein	O
binding	O
”,	O
“	O
poly	O
(	O
A	O
)	O
RNA	O
binding	O
”,	O
“	O
ion	O
channel	O
binding	O
”,	O
and	O
“	O
actin	B-GP
filament	O
binding	O
”	O
in	O
the	O
molecular	O
function	O
category	O
,	O
and	O
“	O
cytosol	O
”,	O
“	O
postsynaptic	O
density	O
”,	O
“	O
neuronal	O
projection	O
”,	O
and	O
“	O
dendritic	O
spine	O
”	O
in	O
the	O
cellular	O
component	O
category	O
,	O
and	O
“	O
carbon	O
metabolism	O
”	O
in	O
the	O
KEGG	O
pathway	O
were	O
significantly	O
associated	O
with	O
these	O
interactors	O
(	O
Figure	O
2D	O
and	O
Supplementary	O
Table	O
S7	O
).	O

Together	O
,	O
these	O
results	O
suggest	O
a	O
high	O
connectivity	O
between	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
,	O
mediated	O
by	O
94	O
common	O
interacting	O
proteins	O
involved	O
in	O
defined	O
biological	O
pathways	O
(	O
for	O
simplicity	O
,	O
we	O
will	O
refer	O
to	O
these	O
94	O
proteins	O
as	O
“	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
”).	O

Actin	B-GP
-	I-GP
Related	I-GP
Proteins	I-GP
in	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
Interactome	O

From	O
the	O
GO	O
and	O
KEGG	O
pathway	O
analysis	O
,	O
we	O
could	O
identify	O
several	O
molecular	O
/	O
biological	O
functions	O
of	O
the	O
94	O
proteins	O
from	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
.	O

Among	O
them	O
,	O
we	O
hypothesized	O
that	O
actin	B-GP
regulatory	O
pathway	O
might	O
be	O
important	O
,	O
because	O
ACTN2	B-GP
,	O
an	O
actin	B-GP
filament	O
bundling	O
protein	O
(	O
Djinovic	O
-	O
Carugo	O
et	O
al	O
.,	O
1999	O
),	O
was	O
identified	O
as	O
the	O
only	O
common	O
interactor	O
for	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
,	O
and	O
Rhes	B-GP
.	O

Moreover	O
,	O
PICK1	B-GP
,	O
a	O
common	O
interactor	O
for	O
Shank3	B-GP
and	O
TSC1	B-GP
/	O
TSC2	B-GP
,	O
is	O
also	O
involved	O
in	O
regulating	O
actin	B-GP
cytoskeleton	O
by	O
inhibiting	O
the	O
actin	B-GP
-	O
nucleating	O
Arp2	B-GP
/	O
3	O
complex	O
(	O
Rocca	O
et	O
al	O
.,	O
2008	O
).	O

Previously	O
,	O
we	O
generated	O
a	O
subnetwork	O
of	O
Shank3	B-GP
interactome	O
consisting	O
of	O
only	O
38	O
actin	B-GP
-	I-GP
related	I-GP
proteins	I-GP
from	O
the	O
original	O
Shank3	B-GP
interactome	O
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

We	O
found	O
that	O
among	O
the	O
38	O
actin	B-GP
-	O
related	O
interactors	O
of	O
Shank3	B-GP
,	O
11	O
proteins	O
(	O
approximately	O
29	O
%)	O
were	O
shared	O
with	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
(	O
Figure	O
3A	O
).	O

Specifically	O
,	O
we	O
noticed	O
that	O
the	O
Wiskott	B-GP
-	I-GP
Aldrich	I-GP
syndrome	I-GP
protein	I-GP
family	I-GP
verprolin	I-GP
-	I-GP
homologous	I-GP
protein	I-GP
1	I-GP
(	O
WAVE1	B-GP
,	O
encoded	O
by	O
WASF1	B-GP
)	O
and	O
Abelson	B-GP
-	I-GP
interacting	I-GP
protein	I-GP
1	I-GP
(	O
Abi1	B-GP
)	O
proteins	O
,	O
the	O
critical	O
components	O
of	O
the	O
WAVE	B-GP
regulatory	O
complex	O
(	O
WRC	O
),	O
and	O
Ras	B-GP
-	I-GP
related	I-GP
C3	I-GP
botulinum	I-GP
toxin	I-GP
substrate	I-GP
1	I-GP
(	O
Rac1	B-GP
),	O
the	O
upstream	O
regulator	O
of	O
the	O
WRC	O
,	O
were	O
among	O
these	O
11	O
proteins	O
(	O
Figure	O
3A	O
).	O

The	O
WRC	O
is	O
an	O
approximately	O
400	O
kDa	O
heteropentameric	O
protein	O
complex	O
that	O
consists	O
of	O
WAVE	B-GP
,	O
Abi	B-GP
,	O
Cytoplasmic	B-GP
FMR1	I-GP
-	I-GP
interacting	I-GP
protein	I-GP
(	O
Cyfip	B-GP
),	O
Nck	B-GP
-	I-GP
associated	I-GP
protein	I-GP
(	O
Nap	B-GP
)	O
and	O
Hematopoietic	O
stem	O
progenitor	O
cell	O
300	O
(	O
HSPC300	O
)	O
and	O
activates	O
the	O
Arp2	B-GP
/	O
3	O
complex	O
to	O
initiate	O
actin	B-GP
polymerization	O
and	O
branching	O
(	O
Takenawa	O
and	O
Suetsugu	O
,	O
2007	O
;	O
Chen	O
Z	O
.	O
et	O
al	O
.,	O
2010	O
;	O
Han	O
et	O
al	O
.,	O
2015	O
).	O

Actin	B-GP
-	I-GP
related	I-GP
proteins	I-GP
in	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
,	O
and	O
increased	O
F	B-GP
-	I-GP
actin	I-GP
levels	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
.	O
(	O
A	O
)	O
The	O
actin	B-GP
-	O
related	O
subnetwork	O
of	O
Shank3	B-GP
interactome	O
where	O
the	O
11	O
proteins	O
shared	O
by	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
are	O
colored	O
in	O
red	O
.	O

The	O
edges	O
of	O
the	O
network	O
are	O
colored	O
depending	O
on	O
the	O
type	O
of	O
interactions	O
(	O
direct	O
or	O
indirect	O
interaction	O
).	O

The	O
red	O
dotted	O
circle	O
indicates	O
the	O
components	O
of	O
wave	B-GP
regulatory	O
complex	O
(	O
WRC	O
;	O
WASF1	B-GP
;	O
Abelson	B-GP
-	I-GP
interacting	I-GP
protein	I-GP
1	I-GP
(	O
ABI1	B-GP
),	O
ABI2	B-GP
and	O
Cytoplasmic	B-GP
FMR1	I-GP
-	I-GP
interacting	I-GP
protein	I-GP
2	I-GP
(	O
CYFIP2	B-GP
)	O
and	O
Ras	B-GP
-	I-GP
related	I-GP
C3	I-GP
botulinum	I-GP
toxin	I-GP
substrate	I-GP
1	I-GP
(	O
RAC1	B-GP
)).	O
(	O
B	O
)	O
The	O
diagrams	O
show	O
the	O
atlas	O
of	O
mouse	B-OG
brain	O
coronal	O
sections	O
for	O
the	O
striatum	O
,	O
and	O
the	O
coordinates	O
of	O
the	O
exact	O
areas	O
where	O
immunohistochemistry	O
(	O
IHC	O
)	O
experiments	O
were	O
performed	O
(	O
left	O
panel	O
).	O

The	O
green	O
boxes	O
indicate	O
regions	O
of	O
interests	O
(	O
ROIs	O
).	O

Representative	O
IHC	O
images	O
show	O
expression	O
of	O
the	O
EGFP	B-GP
-	O
Shank3	B-GP
proteins	O
in	O
the	O
dorsal	O
striatum	O
of	O
Shank3	B-GP
TG	O
,	O
but	O
not	O
WT	O
,	O
mice	B-OG
(	O
right	O
panel	O
).	O

DL	O
,	O
dorsolateral	O
;	O
DM	O
,	O
dorsomedial	O
;	O
DV	O
,	O
dorsoventral	O
.	O

Scale	O
bar	O
,	O
500	O
μm	O
.	O
(	O
C	O
)	O
Representative	O
IHC	O
images	O
and	O
quantification	O
show	O
increased	O
levels	O
of	O
F	B-GP
-	I-GP
actin	I-GP
in	O
the	O
DV	O
,	O
but	O
not	O
DM	O
and	O
DL	O
,	O
compartments	O
of	O
Shank3	B-GP
TG	O
striatum	O
.	O

Scale	O
bar	O
,	O
500	O
μm	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
7	O
animals	B-OG
per	O
genotype	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
unpaired	O
two	O
-	O
tailed	O
Student	O
’	O
s	O
t	O
-	O
test	O
).	O
(	O
D	O
)	O
Western	O
blot	O
images	O
show	O
co	O
-	O
immunoprecipitation	O
(	O
IP	O
)	O
of	O
EGFP	B-GP
-	O
Shank3	B-GP
,	O
Rhes	B-GP
,	O
WAVE1	B-GP
,	O
and	O
Homer1b	B-GP
/	I-GP
c	I-GP
proteins	O
from	O
the	O
Shank3	B-GP
TG	O
,	O
but	O
not	O
WT	O
,	O
synaptosomal	O
lysate	O
.	O

For	O
input	O
and	O
flow	O
-	O
through	O
(	O
F	O
/	O
T	O
)	O
lanes	O
,	O
0	O
.	O
5	O
%	O
of	O
total	O
proteins	O
were	O
loaded	O
.	O

This	O
result	O
prompted	O
us	O
to	O
test	O
whether	O
the	O
levels	O
of	O
polymerized	O
actin	B-GP
(	O
actin	B-GP
filament	O
or	O
F	B-GP
-	I-GP
actin	I-GP
)	O
were	O
increased	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

We	O
previously	O
showed	O
that	O
synaptic	O
F	B-GP
-	I-GP
actin	I-GP
levels	O
were	O
increased	O
in	O
the	O
cultured	O
hippocampal	O
neurons	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

However	O
,	O
this	O
has	O
not	O
been	O
validated	O
in	O
vivo	O
,	O
especially	O
in	O
the	O
striatum	O
where	O
Shank3	B-GP
is	O
enriched	O
compared	O
to	O
other	O
brain	O
regions	O
.	O

For	O
the	O
analysis	O
,	O
we	O
focused	O
on	O
the	O
dorsal	O
striatum	O
,	O
the	O
area	O
in	O
which	O
the	O
functional	O
and	O
morphological	O
changes	O
of	O
striatal	O
synapses	O
in	O
the	O
Shank3	B-GP
KO	O
mice	B-OG
have	O
been	O
mainly	O
characterized	O
(	O
Peça	O
et	O
al	O
.,	O
2011	O
;	O
Peixoto	O
et	O
al	O
.,	O
2016	O
;	O
Wang	O
et	O
al	O
.,	O
2016	O
;	O
Jaramillo	O
et	O
al	O
.,	O
2017	O
).	O

In	O
addition	O
,	O
the	O
dorsal	O
striatum	O
is	O
closely	O
associated	O
with	O
motor	O
and	O
executive	O
functions	O
(	O
Balleine	O
and	O
O	O
’	O
Doherty	O
,	O
2010	O
)	O
both	O
of	O
which	O
are	O
defective	O
in	O
mania	B-DS
(	O
Marvel	O
and	O
Paradiso	O
,	O
2004	O
).	O

Nevertheless	O
,	O
to	O
more	O
precisely	O
characterize	O
F	B-GP
-	I-GP
actin	I-GP
changes	O
,	O
we	O
subdivided	O
the	O
dorsal	O
striatum	O
into	O
three	O
subareas	O
;	O
DL	O
,	O
DM	O
and	O
DV	O
compartments	O
,	O
characterized	O
by	O
distinct	O
cellular	O
compositions	O
,	O
synaptic	O
inputs	O
/	O
outputs	O
,	O
and	O
functional	O
roles	O
in	O
controlling	O
behavior	O
(	O
Steiner	O
and	O
Tseng	O
,	O
2010	O
;	O
Ito	O
and	O
Doya	O
,	O
2015	O
;	O
Matamales	O
et	O
al	O
.,	O
2016	O
;	O
Figure	O
3B	O
).	O

First	O
,	O
we	O
carefully	O
set	O
the	O
scanning	O
parameters	O
for	O
fluorescent	O
confocal	O
microscopy	O
,	O
because	O
Shank3	B-GP
TG	O
mice	B-OG
express	O
EGFP	B-GP
-	O
tagged	O
Shank3	B-GP
proteins	O
.	O

Indeed	O
,	O
we	O
found	O
that	O
under	O
the	O
scanning	O
condition	O
for	O
Alexa	O
Fluor	O
488	O
,	O
significant	O
amount	O
of	O
signal	O
was	O
detected	O
from	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
,	O
but	O
not	O
WT	O
,	O
mice	B-OG
(	O
Supplementary	O
Figure	O
S2	O
).	O

Therefore	O
,	O
we	O
decided	O
to	O
use	O
Alexa	O
Fluor	O
594	O
and	O
rhodamine	O
for	O
IHC	O
experiments	O
.	O

Next	O
,	O
we	O
confirmed	O
that	O
the	O
EGFP	B-GP
-	O
Shank3	B-GP
proteins	O
from	O
the	O
transgene	O
were	O
expressed	O
in	O
all	O
three	O
striatal	O
subareas	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Figure	O
3B	O
).	O

Lastly	O
,	O
we	O
measured	O
F	B-GP
-	I-GP
actin	I-GP
levels	O
by	O
staining	O
the	O
striatal	O
sections	O
with	O
rhodamine	O
-	O
conjugated	O
phalloidin	O
,	O
and	O
found	O
that	O
F	B-GP
-	I-GP
actin	I-GP
levels	O
were	O
significantly	O
increased	O
by	O
approximately	O
23	O
%	O
in	O
the	O
DV	O
compartment	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Figure	O
3C	O
).	O

Trends	O
for	O
an	O
increase	O
were	O
also	O
observed	O
in	O
DL	O
(	O
P	O
=	O
0	O
.	O
14	O
)	O
and	O
DM	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
compartments	O
,	O
but	O
the	O
differences	O
were	O
not	O
statistically	O
significant	O
.	O

As	O
a	O
control	O
,	O
the	O
intensity	O
of	O
NeuN	B-GP
staining	O
in	O
the	O
three	O
subareas	O
of	O
the	O
dorsal	O
striatum	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
was	O
comparable	O
to	O
that	O
in	O
WT	O
mice	B-OG
,	O
suggesting	O
a	O
normal	O
neuronal	O
density	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
(	O
Supplementary	O
Figure	O
S3	O
).	O

Previously	O
,	O
Sakai	O
et	O
al	O
.	O
(	O
2011	O
)	O
validated	O
the	O
in	O
vivo	O
interactions	O
of	O
Shank3	B-GP
,	O
TSC1	B-GP
and	O
α	B-GP
-	I-GP
actinin	I-GP
using	O
mouse	B-OG
brain	O
lysates	O
.	O

Therefore	O
,	O
we	O
also	O
tested	O
for	O
the	O
existence	O
of	O
the	O
in	O
vivo	O
protein	O
complex	O
consisting	O
of	O
Shank3	B-GP
,	O
Rhes	B-GP
and	O
WAVE1	B-GP
in	O
the	O
synaptosomal	O
lysate	O
from	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

We	O
performed	O
IP	O
using	O
the	O
GFP	B-GP
-	O
Trap	O
beads	O
to	O
pull	O
down	O
EGFP	B-GP
-	O
Shank3	B-GP
and	O
its	O
interacting	O
proteins	O
from	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
as	O
described	O
previously	O
(	O
Han	O
et	O
al	O
.,	O
2013b	O
;	O
Lee	O
Y	O
.	O
et	O
al	O
.,	O
2017	O
),	O
and	O
found	O
that	O
Shank3	B-GP
,	O
Rhes	B-GP
,	O
WAVE1	B-GP
and	O
Homer1b	B-GP
/	I-GP
c	I-GP
(	O
a	O
known	O
interactor	O
of	O
Shank3	B-GP
)	O
proteins	O
were	O
pulled	O
down	O
together	O
(	O
Figure	O
3D	O
).	O

This	O
result	O
is	O
consistent	O
with	O
the	O
previous	O
study	O
of	O
“	O
Rhesactome	O
”,	O
in	O
which	O
the	O
authors	O
performed	O
IP	O
using	O
Rhes	B-GP
antibodies	O
to	O
pull	O
down	O
endogenous	O
Rhes	B-GP
proteins	O
from	O
the	O
striatal	O
lysate	O
of	O
WT	O
mice	B-OG
,	O
and	O
identified	O
Shank3	B-GP
and	O
WAVE1	B-GP
proteins	O
in	O
the	O
complex	O
using	O
mass	O
spectrometry	O
analysis	O
(	O
Shahani	O
et	O
al	O
.,	O
2016	O
).	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
certain	O
actin	B-GP
-	I-GP
related	I-GP
proteins	I-GP
may	O
be	O
involved	O
in	O
connecting	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
.	O

Associations	O
of	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
Interactome	O
and	O
Shank3	B-GP
TG	O
Transcriptome	O
with	O
the	O
Disease	O

Recent	O
studies	O
have	O
shown	O
that	O
the	O
genes	O
mutated	O
in	O
neurodevelopmental	O
and	O
neuropsychiatric	B-DS
disorders	I-DS
such	O
as	O
ASD	B-DS
or	O
SCZ	B-DS
might	O
also	O
be	O
highly	O
interconnected	O
at	O
the	O
protein	O
level	O
(	O
De	O
Rubeis	O
et	O
al	O
.,	O
2014	O
;	O
Fromer	O
et	O
al	O
.,	O
2014	O
).	O

In	O
this	O
regard	O
,	O
we	O
reasoned	O
that	O
neuropsychiatric	B-DS
disorders	I-DS
affected	O
by	O
pathological	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactions	O
might	O
be	O
identified	O
as	O
those	O
significantly	O
associated	O
with	O
the	O
94	O
proteins	O
connecting	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
.	O

We	O
selected	O
three	O
established	O
disease	O
-	O
associated	O
gene	O
sets	O
;	O
psychiatric	B-DS
disorder	I-DS
-	O
associated	O
PsyGeNET	O
gene	O
sets	O
(	O
Gutierrez	O
-	O
Sacristan	O
et	O
al	O
.,	O
2015	O
),	O
ASD	B-DS
-	O
associated	O
Simons	O
Foundation	O
Autism	B-DS
Research	O
Initiative	O
(	O
SFARI	O
)	O
gene	O
set5	O
,	O
and	O
broad	O
human	B-OG
disease	O
-	O
associated	O
DisGeNET	O
gene	O
sets	O
(	O
Piñero	O
et	O
al	O
.,	O
2017	O
)	O
and	O
compared	O
these	O
gene	O
sets	O
with	O
the	O
94	O
genes	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
.	O

We	O
found	O
that	O
among	O
the	O
eight	O
major	O
classes	O
of	O
psychiatric	B-DS
disorders	I-DS
in	O
the	O
PsyGeNET	O
,	O
“	O
BDs	O
and	O
related	O
disorders	O
”	O
and	O
“	O
SCZ	B-DS
spectrum	O
and	O
other	O
psychiatric	B-DS
disorders	I-DS
”	O
were	O
significantly	O
associated	O
with	O
the	O
94	O
genes	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
(	O
adjusted	O
P	O
=	O
0	O
.	O
000186	O
for	O
both	O
,	O
hypergeometric	O
test	O
;	O
Figures	O
4A	O
,	O
B	O
and	O
Supplementary	O
Table	O
S8	O
).	O

Moreover	O
,	O
when	O
compared	O
with	O
the	O
entire	O
subclasses	O
(	O
117	O
psychiatric	B-DS
disorders	I-DS
)	O
of	O
PsyGeNET	O
,	O
only	O
four	O
disorders	O
including	O
“	O
SCZ	B-DS
”,	O
“	O
BD	B-DS
”,	O
“	O
manic	O
”	O
and	O
“	O
manic	O
mood	O
”	O
were	O
significantly	O
associated	O
with	O
the	O
94	O
genes	O
(	O
Supplementary	O
Table	O
S8	O
).	O

It	O
is	O
considered	O
that	O
BD	B-DS
and	O
SCZ	B-DS
have	O
many	O
aspects	O
in	O
common	O
,	O
such	O
as	O
risk	O
genes	O
,	O
molecular	O
and	O
neuronal	O
pathophysiology	O
,	O
and	O
clinical	O
symptoms	O
(	O
Berrettini	O
,	O
2000	O
;	O
Benes	O
and	O
Berretta	O
,	O
2001	O
;	O
Moskvina	O
et	O
al	O
.,	O
2009	O
).	O

In	O
contrast	O
to	O
BD	B-DS
and	O
SCZ	B-DS
,	O
the	O
association	O
between	O
ASDs	B-DS
(	O
SFARI	O
genes	O
)	O
and	O
the	O
94	O
genes	O
was	O
not	O
statistically	O
significant	O
(	O
Figure	O
4A	O
).	O

Lastly	O
,	O
among	O
the	O
disease	O
classes	O
of	O
DisGeNET	O
,	O
“	O
SCZ	B-DS
”,	O
“	O
Down	B-DS
syndrome	I-DS
”,	O
“	O
Alzheimer	B-DS
’	I-DS
s	I-DS
disease	I-DS
”,	O
“	O
seizures	O
”	O
and	O
“	O
BD	B-DS
”	O
were	O
among	O
the	O
top	O
disorders	O
significantly	O
associated	O
with	O
the	O
94	O
genes	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
(	O
Figure	O
4A	O
and	O
Supplementary	O
Table	O
S9	O
).	O

Associations	O
of	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
and	O
Shank3	B-GP
TG	O
striatal	O
transcriptome	O
with	O
the	O
disease	O
.	O
(	O
A	O
)	O
Disease	O
association	O
analysis	O
for	O
the	O
94	O
genes	O
in	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
.	O

Significant	O
disease	O
terms	O
(	O
Benjamini	O
adjusted	O
P	O
value	O
<	O
0	O
.	O
05	O
)	O
are	O
in	O
bold	O
red	O
.	O

The	O
complete	O
analyses	O
are	O
provided	O
in	O
Supplementary	O
Tables	O
S8	O
,	O
S9	O
.	O
(	O
B	O
)	O
The	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
network	O
with	O
bipolar	B-DS
disorder	I-DS
(	O
BD	B-DS
)-	O
and	O
schizophrenia	B-DS
(	O
SCZ	B-DS
)-	O
associated	O
proteins	O
from	O
Psychiatric	B-DS
disorders	I-DS
Gene	O
association	O
NETwork	O
(	O
PsyGeNET	O
)	O
database	O
colored	O
in	O
red	O
.	O
(	O
C	O
)	O
The	O
bar	O
graph	O
shows	O
the	O
Normalized	O
Enrichment	O
Scores	O
(	O
NESs	O
)	O
of	O
GSEA	O
on	O
the	O
PsyGeNET	O
gene	O
sets	O
for	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Significant	O
disease	O
terms	O
are	O
in	O
bold	O
red	O
.	O

The	O
complete	O
list	O
of	O
GSEA	O
is	O
provided	O
in	O
Supplementary	O
Table	O
S10	O
.	O
(	O
D	O
)	O
The	O
enrichment	O
plots	O
showing	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
on	O
the	O
PsyGeNET	O
gene	O
sets	O
of	O
“	O
depressive	B-DS
disorders	I-DS
”	O
(	O
left	O
panel	O
)	O
and	O
“	O
BD	B-DS
and	O
related	O
disorders	O
”	O
(	O
right	O
panel	O
).	O

The	O
above	O
mentioned	O
result	O
showing	O
a	O
significant	O
association	O
between	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
and	O
BD	B-DS
prompted	O
us	O
to	O
test	O
whether	O
the	O
overall	O
transcriptomic	O
change	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
might	O
also	O
be	O
associated	O
with	O
BD	B-DS
or	O
other	O
psychiatric	B-DS
disorders	I-DS
.	O

We	O
therefore	O
preformed	O
GSEA	O
of	O
the	O
Shank3	B-GP
TG	O
RNA	O
-	O
seq	O
results	O
with	O
the	O
PsyGeNET	O
gene	O
sets	O
.	O

We	O
found	O
that	O
more	O
PsyGeNET	O
gene	O
sets	O
were	O
significantly	O
associated	O
with	O
the	O
RNA	O
-	O
seq	O
results	O
than	O
with	O
the	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
.	O

In	O
addition	O
to	O
SCZ	B-DS
and	O
BD	B-DS
,	O
“	O
depressive	B-DS
disorders	I-DS
”,	O
“	O
alcohol	B-DS
use	I-DS
disorders	I-DS
”,	O
and	O
“	O
cocaine	B-DS
use	I-DS
disorders	I-DS
”	O
gene	O
sets	O
were	O
significantly	O
represented	O
by	O
the	O
genes	O
up	O
-	O
regulated	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
(	O
Figures	O
4C	O
,	O
D	O
and	O
Supplementary	O
Table	O
S10	O
).	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
both	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
and	O
striatal	O
transcriptome	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
may	O
be	O
associated	O
with	O
BD	B-DS
.	O

Discussion	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
elucidate	O
the	O
molecular	O
pathophysiology	O
underlying	O
striatal	O
dysfunction	O
in	O
mania	B-DS
.	O

We	O
performed	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
-	O
overexpressing	O
manic	O
mouse	B-OG
model	O
and	O
identified	O
mTORC1	B-GP
signaling	O
as	O
the	O
primary	O
molecular	O
signature	O
.	O

Based	O
on	O
the	O
RNA	O
-	O
seq	O
analysis	O
,	O
we	O
examined	O
mTORC1	B-GP
activity	O
and	O
found	O
that	O
it	O
was	O
decreased	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Although	O
the	O
RNA	O
-	O
seq	O
analysis	O
revealed	O
altered	O
mTORC1	B-GP
activity	O
,	O
we	O
consider	O
that	O
the	O
gene	O
expression	O
changes	O
related	O
to	O
mTORC1	B-GP
signaling	O
could	O
be	O
a	O
secondary	O
or	O
compensatory	O
effect	O
of	O
decreased	O
mTORC1	B-GP
activity	O
for	O
several	O
reasons	O
.	O

First	O
,	O
the	O
GSEA	O
revealed	O
that	O
mTORC1	B-GP
signaling	O
was	O
depicted	O
by	O
the	O
genes	O
up	O
-	O
regulated	O
in	O
Shank3	B-GP
TG	O
striatum	O
,	O
which	O
is	O
opposite	O
to	O
the	O
change	O
of	O
striatal	O
mTORC1	B-GP
activity	O
.	O

Second	O
,	O
Shank3	B-GP
proteins	O
mainly	O
function	O
at	O
the	O
excitatory	O
postsynapse	O
,	O
and	O
are	O
thus	O
less	O
likely	O
to	O
directly	O
regulate	O
a	O
group	O
of	O
genes	O
specifically	O
related	O
to	O
mTORC1	B-GP
signaling	O
.	O

Notably	O
,	O
it	O
was	O
recently	O
reported	O
that	O
Shank3	B-GP
proteins	O
can	O
undergo	O
synapse	O
-	O
to	O
-	O
nucleus	O
shuttling	O
in	O
an	O
activity	O
-	O
dependent	O
manner	O
,	O
and	O
that	O
Shank3	B-GP
localized	O
in	O
the	O
nucleus	O
may	O
regulate	O
the	O
expression	O
of	O
several	O
genes	O
such	O
as	O
leucine	B-GP
rich	I-GP
repeat	I-GP
transmembrane	I-GP
neuronal	I-GP
1	I-GP
(	O
Lrrtm1	B-GP
),	O
synaptotagmin	B-GP
I	I-GP
(	O
Syt1	B-GP
),	O
and	O
cystic	B-GP
fibrosis	I-GP
transmembrane	I-GP
conductance	I-GP
regulator	I-GP
homolog	O
(	O
Cftr	B-GP
;	O
Grabrucker	O
et	O
al	O
.,	O
2014	O
).	O

However	O
,	O
none	O
of	O
these	O
potential	O
“	O
Shank3	B-GP
target	O
genes	O
”	O
was	O
listed	O
among	O
mTORC1	B-GP
signaling	O
-	O
related	O
genes	O
from	O
our	O
RNA	O
-	O
seq	O
analysis	O
(	O
Supplementary	O
Table	O
S5	O
),	O
suggesting	O
that	O
mTORC1	B-GP
signaling	O
-	O
related	O
genes	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
were	O
not	O
directly	O
up	O
-	O
regulated	O
by	O
nuclear	O
Shank3	B-GP
proteins	O
.	O

Although	O
we	O
did	O
not	O
characterize	O
them	O
in	O
details	O
,	O
there	O
were	O
several	O
interesting	O
differentially	O
expressed	O
genes	O
(	O
DEGs	O
)	O
from	O
the	O
striatal	O
RNA	O
-	O
seq	O
analysis	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

For	O
example	O
,	O
an	O
up	O
-	O
regulated	O
GPR85	B-GP
(	O
also	O
called	O
SREB2	B-GP
for	O
super	B-GP
-	I-GP
conserved	I-GP
receptor	I-GP
expressed	I-GP
in	I-GP
brain	I-GP
)	O
gene	O
,	O
encoding	O
a	O
highly	O
conserved	O
G	B-GP
protein	I-GP
-	I-GP
coupled	I-GP
receptor	I-GP
,	O
has	O
been	O
associated	O
with	O
SCZ	B-DS
(	O
Matsumoto	O
et	O
al	O
.,	O
2008	O
;	O
Radulescu	O
et	O
al	O
.,	O
2013	O
).	O

Notably	O
,	O
the	O
Gpr85	B-GP
TG	O
mice	B-OG
mildly	O
overexpressing	O
GPR85	B-GP
proteins	O
display	O
some	O
abnormal	O
behaviors	O
including	O
impaired	O
prepulse	O
inhibition	O
and	O
decreased	O
social	O
interaction	O
(	O
Matsumoto	O
et	O
al	O
.,	O
2008	O
),	O
which	O
were	O
also	O
seen	O
in	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

Therefore	O
,	O
the	O
effects	O
from	O
DEGs	O
,	O
together	O
with	O
decreased	O
mTORC1	B-GP
activity	O
,	O
might	O
contribute	O
to	O
the	O
behavioral	O
phenotypes	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

To	O
understand	O
the	O
detailed	O
mechanism	O
underlying	O
decreased	O
mTORC1	B-GP
activity	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
,	O
we	O
re	O
-	O
analyzed	O
the	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
protein	O
interactomes	O
side	O
by	O
side	O
.	O

This	O
was	O
based	O
on	O
the	O
previous	O
reports	O
showing	O
the	O
PPI	O
-	O
mediated	O
connectivity	O
between	O
Shank3	B-GP
and	O
TSC1	B-GP
/	O
TSC2	B-GP
(	O
Sakai	O
et	O
al	O
.,	O
2011	O
),	O
and	O
the	O
striatal	O
in	O
vivo	O
Rhes	B-GP
protein	O
complex	O
(“	O
Rhesactome	O
”)	O
containing	O
Shank3	B-GP
and	O
several	O
Shank3	B-GP
-	O
interacting	O
proteins	O
(	O
Shahani	O
et	O
al	O
.,	O
2016	O
).	O

Indeed	O
,	O
we	O
could	O
identify	O
94	O
proteins	O
connecting	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
(	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
).	O

However	O
,	O
one	O
of	O
the	O
limitations	O
of	O
this	O
interactome	O
is	O
not	O
being	O
strict	O
enough	O
to	O
fully	O
represent	O
the	O
in	O
vivo	O
connections	O
among	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
,	O
because	O
some	O
of	O
the	O
interactions	O
,	O
especially	O
those	O
for	O
TSC1	B-GP
/	O
TSC2	B-GP
,	O
were	O
identified	O
based	O
only	O
on	O
in	O
vitro	O
Y2H	O
screening	O
.	O

Nevertheless	O
,	O
Shank3	B-GP
-	O
TSC1	B-GP
(	O
Sakai	O
et	O
al	O
.,	O
2011	O
)	O
and	O
Shank3	B-GP
-	O
Rhes	B-GP
(	O
Figure	O
3D	O
)	O
interactions	O
were	O
validated	O
in	O
the	O
mouse	B-OG
brain	O
lysates	O
,	O
indicating	O
the	O
existence	O
of	O
protein	O
complexes	O
containing	O
Shank3	B-GP
,	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
in	O
vivo	O
.	O

The	O
mechanism	O
underlying	O
the	O
decrease	O
in	O
mTORC1	B-GP
activity	O
in	O
response	O
to	O
interactions	O
between	O
Shank3	B-GP
and	O
the	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
remains	O
unclear	O
.	O

One	O
possibility	O
is	O
that	O
Shank3	B-GP
overexpression	O
might	O
shift	O
or	O
sequester	O
TSC1	B-GP
/	O
TSC2	B-GP
and	O
Rhes	B-GP
proteins	O
from	O
mTORC1	B-GP
regulatory	O
complex	O
to	O
actin	B-GP
filaments	O
-	O
related	O
complex	O
and	O
thereby	O
disturb	O
the	O
maintenance	O
of	O
normal	O
mTORC1	B-GP
activity	O
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
we	O
found	O
that	O
11	O
of	O
the	O
94	O
proteins	O
from	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
,	O
including	O
ACTN2	B-GP
,	O
WAVE1	B-GP
,	O
Abi	B-GP
and	O
Rac1	B-GP
,	O
were	O
associated	O
with	O
actin	B-GP
filaments	O
,	O
and	O
that	O
levels	O
of	O
F	B-GP
-	I-GP
actin	I-GP
were	O
increased	O
in	O
the	O
dorsal	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Similarly	O
,	O
it	O
was	O
recently	O
shown	O
that	O
,	O
in	O
the	O
mouse	B-OG
striatum	O
,	O
RasGRP1	B-GP
suppresses	O
the	O
inhibitory	O
role	O
of	O
Rhes	B-GP
in	O
amphetamine	O
-	O
induced	O
dopamine	B-GP
receptor	I-GP
signaling	O
,	O
by	O
promoting	O
Rhes	B-GP
to	O
form	O
a	O
specific	O
protein	O
complex	O
(	O
Shahani	O
et	O
al	O
.,	O
2016	O
).	O

Further	O
biochemical	O
and	O
/	O
or	O
imaging	O
analyses	O
are	O
necessary	O
to	O
fully	O
understand	O
the	O
functional	O
significance	O
of	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
in	O
the	O
regulation	O
of	O
the	O
striatal	O
mTORC1	B-GP
activity	O
.	O

Moreover	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
altered	O
mTORC1	B-GP
activity	O
might	O
contribute	O
to	O
the	O
increased	O
F	B-GP
-	I-GP
actin	I-GP
levels	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

It	O
has	O
been	O
shown	O
that	O
mTORC1	B-GP
and	O
mTORC2	B-GP
regulate	O
motility	O
and	O
metastasis	O
of	O
colorectal	B-DS
cancer	I-DS
cells	O
via	O
modulating	O
Ras	B-GP
homolog	I-GP
gene	I-GP
family	I-GP
,	I-GP
member	I-GP
A	I-GP
(	O
RhoA	B-GP
)	O
and	O
Rac1	B-GP
signaling	O
(	O
Gulhati	O
et	O
al	O
.,	O
2011	O
).	O

It	O
is	O
notable	O
that	O
mTORC1	B-GP
activity	O
is	O
also	O
decreased	O
in	O
the	O
neurons	O
with	O
reduced	O
Shank3	B-GP
expression	O
,	O
due	O
to	O
increased	O
steady	O
-	O
state	O
levels	O
of	O
CLK2	B-GP
(	O
Bidinosti	O
et	O
al	O
.,	O
2016	O
).	O

The	O
CLK2	B-GP
phosphorylates	O
and	O
activates	O
the	O
regulatory	O
subunit	O
of	O
protein	B-GP
phosphatase	I-GP
2A	I-GP
(	O
PP2A	B-GP
)	O
which	O
in	O
turn	O
inactivates	O
Akt	B-GP
,	O
a	O
positive	O
regulator	O
of	O
mTORC1	B-GP
.	O

However	O
,	O
this	O
mechanism	O
could	O
not	O
explain	O
the	O
decrease	O
in	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
where	O
Akt	B-GP
activity	O
was	O
found	O
to	O
be	O
normal	O
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

Thus	O
,	O
either	O
loss	O
or	O
gain	O
of	O
Shank3	B-GP
expression	O
can	O
induce	O
a	O
decrease	O
in	O
mTORC1	B-GP
activity	O
,	O
most	O
likely	O
,	O
via	O
different	O
mechanisms	O
,	O
the	O
details	O
of	O
which	O
will	O
be	O
an	O
interesting	O
topic	O
for	O
future	O
research	O
.	O

Despite	O
normal	O
Akt	B-GP
activity	O
in	O
the	O
Shank3	B-GP
TG	O
striatum	O
,	O
however	O
,	O
treatments	O
with	O
certain	O
molecules	O
that	O
increase	O
Akt	B-GP
activity	O
such	O
as	O
IGF1	B-GP
,	O
might	O
possibly	O
rescue	O
the	O
decreased	O
striatal	O
mTORC1	B-GP
activity	O
and	O
some	O
behavioral	O
abnormalities	O
in	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Importantly	O
,	O
the	O
treatment	O
with	O
IGF1	B-GP
has	O
already	O
been	O
shown	O
as	O
a	O
promising	O
potential	O
therapeutic	O
approach	O
for	O
the	O
disorders	O
caused	O
by	O
SHANK3	B-GP
deficiency	O
in	O
model	O
system	O
studies	O
and	O
a	O
pilot	O
clinical	O
trial	O
(	O
Bozdagi	O
et	O
al	O
.,	O
2013	O
;	O
Shcheglovitov	O
et	O
al	O
.,	O
2013	O
;	O
Kolevzon	O
et	O
al	O
.,	O
2014	O
;	O
Bidinosti	O
et	O
al	O
.,	O
2016	O
).	O

By	O
performing	O
Western	O
blot	O
experiments	O
,	O
we	O
found	O
a	O
mild	O
(	O
approximately	O
15	O
%)	O
decrease	O
of	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

While	O
several	O
types	O
of	O
neurons	O
can	O
be	O
found	O
in	O
the	O
striatum	O
,	O
MSNs	O
,	O
the	O
GABAergic	O
output	O
neurons	O
of	O
the	O
striatum	O
,	O
account	O
for	O
the	O
majority	O
(>	O
90	O
%)	O
of	O
the	O
population	O
.	O

The	O
MSNs	O
can	O
be	O
further	O
classified	O
into	O
D1	O
and	O
D2	O
-	O
type	O
neurons	O
based	O
on	O
the	O
type	O
of	O
dopamine	B-GP
receptor	I-GP
expressed	O
and	O
projection	O
pathway	O
(	O
striatonigral	O
direct	O
pathway	O
and	O
striatopallidal	O
indirect	O
pathway	O
,	O
respectively	O
;	O
Calabresi	O
et	O
al	O
.,	O
2014	O
).	O

It	O
has	O
been	O
reported	O
that	O
the	O
excitatory	O
synapses	O
of	O
MSNs	O
in	O
Shank3	B-GP
KO	O
mice	B-OG
show	O
morphological	O
and	O
functional	O
abnormalities	O
(	O
Peça	O
et	O
al	O
.,	O
2011	O
;	O
Peixoto	O
et	O
al	O
.,	O
2016	O
;	O
Wang	O
et	O
al	O
.,	O
2016	O
;	O
Jaramillo	O
et	O
al	O
.,	O
2017	O
).	O

However	O
,	O
these	O
studies	O
did	O
not	O
address	O
whether	O
D1	O
and	O
D2	O
-	O
type	O
MSNs	O
could	O
be	O
differentially	O
affected	O
by	O
the	O
loss	O
of	O
Shank3	B-GP
expression	O
.	O

Importantly	O
,	O
Wang	O
et	O
al	O
.	O
(	O
2017	O
)	O
recently	O
showed	O
that	O
several	O
striatal	O
synaptic	O
functions	O
are	O
selectively	O
impaired	O
in	O
the	O
striatopallidal	O
D2	O
-	O
type	O
MSNs	O
in	O
a	O
line	O
of	O
Shank3	B-GP
KO	O
(	O
Shank3B	O
KO	O
)	O
mice	B-OG
.	O

In	O
the	O
same	O
regard	O
,	O
the	O
striatal	O
mTORC1	B-GP
activity	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
may	O
be	O
preferentially	O
,	O
or	O
even	O
specifically	O
,	O
decreased	O
in	O
the	O
D1	O
or	O
D2	O
-	O
type	O
MSNs	O
,	O
but	O
this	O
decrease	O
may	O
be	O
masked	O
by	O
normal	O
mTORC1	B-GP
activity	O
of	O
the	O
remaining	O
neuronal	O
populations	O
.	O

More	O
comprehensive	O
analyses	O
regarding	O
the	O
activities	O
of	O
mTORC1	B-GP
in	O
different	O
neuronal	O
populations	O
of	O
the	O
striatum	O
of	O
both	O
Shank3	B-GP
KO	O
and	O
TG	O
mice	B-OG
will	O
be	O
important	O
,	O
especially	O
considering	O
that	O
D1	O
and	O
D2	O
-	O
type	O
MSNs	O
of	O
the	O
striatum	O
have	O
distinct	O
,	O
or	O
even	O
opposite	O
,	O
roles	O
in	O
controlling	O
behavior	O
(	O
Kravitz	O
et	O
al	O
.,	O
2010	O
).	O

Another	O
important	O
remaining	O
issue	O
is	O
whether	O
decreased	O
striatal	O
mTORC1	B-GP
activity	O
is	O
causally	O
associated	O
with	O
manic	O
-	O
like	O
behaviors	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

This	O
issue	O
could	O
be	O
addressed	O
by	O
testing	O
the	O
effects	O
of	O
drugs	O
,	O
such	O
as	O
IGF1	B-GP
,	O
that	O
can	O
increase	O
mTORC1	B-GP
activity	O
on	O
the	O
manic	O
-	O
like	O
behaviors	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

In	O
this	O
case	O
,	O
however	O
,	O
treatment	O
during	O
the	O
development	O
may	O
be	O
critical	O
given	O
the	O
possibility	O
that	O
the	O
decrease	O
in	O
mTORC1	B-GP
activity	O
starts	O
during	O
early	O
development	O
and	O
chronically	O
affects	O
the	O
striatum	O
to	O
finally	O
result	O
in	O
an	O
adult	O
onset	O
of	O
manic	O
-	O
like	O
behaviors	O
.	O

This	O
is	O
possible	O
because	O
at	O
least	O
Shank3	B-GP
expression	O
itself	O
is	O
increased	O
starting	O
at	O
juvenile	O
(	O
approximately	O
3	O
-	O
week	O
-	O
old	O
)	O
stage	O
in	O
the	O
Shank3	B-GP
TG	O
mice	B-OG
compared	O
to	O
WT	O
mice	B-OG
(	O
Han	O
et	O
al	O
.,	O
2013b	O
).	O

We	O
found	O
that	O
,	O
unlike	O
in	O
the	O
striatum	O
,	O
mTORC1	B-GP
activity	O
was	O
normal	O
in	O
the	O
hippocampus	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

However	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
mTORC1	B-GP
activities	O
in	O
other	O
brain	O
regions	O
,	O
such	O
as	O
frontal	O
cortex	O
and	O
cerebellum	O
,	O
could	O
be	O
altered	O
and	O
contribute	O
to	O
manic	O
-	O
like	O
behaviors	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Interestingly	O
,	O
it	O
has	O
been	O
shown	O
that	O
intracerebroventricular	O
injection	O
of	O
ouabain	O
,	O
an	O
inhibitor	O
of	O
Na	B-GP
/	I-GP
K	I-GP
-	I-GP
ATPase	I-GP
,	O
increases	O
Akt	B-GP
and	O
mTORC1	B-GP
activities	O
in	O
the	O
frontal	O
cortex	O
and	O
causes	O
manic	O
-	O
like	O
behaviors	O
in	O
rats	B-OG
(	O
Yu	O
et	O
al	O
.,	O
2010	O
;	O
Kim	O
S	O
.	O

H	O
.	O
et	O
al	O
.,	O
2013	O
).	O

Therefore	O
,	O
mTORC1	B-GP
activities	O
of	O
different	O
brain	O
regions	O
might	O
have	O
distinct	O
,	O
or	O
even	O
opposite	O
,	O
roles	O
in	O
causing	O
manic	O
-	O
like	O
behaviors	O
.	O

Even	O
with	O
these	O
remaining	O
issues	O
,	O
our	O
bioinformatic	O
analysis	O
showed	O
that	O
both	O
the	O
genes	O
belonging	O
to	O
Shank3	B-GP
-	O
mTORC1	B-GP
interactome	O
and	O
the	O
up	O
-	O
regulated	O
transcriptome	O
of	O
Shank3	B-GP
TG	O
striatum	O
were	O
significantly	O
associated	O
with	O
the	O
PsyGeNET	O
BD	B-DS
genes	O
(	O
Figure	O
4	O
).	O

Therefore	O
,	O
investigating	O
the	O
role	O
of	O
these	O
Shank3	B-GP
-	O
related	O
BD	B-DS
genes	O
,	O
together	O
with	O
mTORC1	B-GP
signaling	O
,	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
might	O
enable	O
us	O
to	O
fully	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
manic	O
-	O
like	O
behaviors	O
in	O
these	O
mice	B-OG
.	O

In	O
conclusion	O
,	O
our	O
results	O
suggest	O
a	O
decrease	O
in	O
mTORC1	B-GP
activity	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
that	O
may	O
be	O
potentially	O
mediated	O
by	O
the	O
PPI	O
-	O
dependent	O
connectivity	O
between	O
Shank3	B-GP
and	O
several	O
upstream	O
regulators	O
of	O
mTORC1	B-GP
.	O

Decreased	O
striatal	O
mTORC1	B-GP
activity	O
might	O
contribute	O
to	O
manic	O
-	O
like	O
behaviors	O
in	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
but	O
further	O
investigation	O
is	O
needed	O
to	O
validate	O
such	O
hypothesis	O
.	O

Since	O
both	O
Shank3	B-GP
and	O
mTORC1	B-GP
signaling	O
are	O
implicated	O
in	O
a	O
broad	O
spectrum	O
of	O
neurodevelopmental	O
and	O
neuropsychiatric	B-DS
disorders	I-DS
,	O
the	O
connectivity	O
between	O
these	O
two	O
proteins	O
may	O
be	O
an	O
important	O
converging	O
pathophysiological	O
pathway	O
as	O
well	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
the	O
treatment	O
of	O
various	O
brain	B-DS
disorders	I-DS
.	O

Author	O
Contributions	O

YL	O
,	O
SGK	O
,	O
BL	O
,	O
YZ	O
,	O
YK	O
,	O
SK	O
and	O
KH	O
designed	O
and	O
performed	O
the	O
experiments	O
.	O

HK	O
and	O
KH	O
analyzed	O
and	O
interpreted	O
the	O
data	O
.	O

EK	O
discussed	O
the	O
project	O
and	O
provided	O
reagents	O
.	O

YL	O
,	O
HK	O
and	O
KH	O
wrote	O
the	O
article	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
manuscript	O
.	O

Conflict	O
of	O
Interest	O
Statement	O

The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

1http	O
://	O
software	O
.	O
broadinstitute	O
.	O
org	O
/	O
gsea	O

2http	O
://	O
software	O
.	O
broadinstitute	O
.	O
org	O
/	O
gsea	O
/	O
msigdb	O

3http	O
://	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
/	O
homology	O
.	O
shtml	O

4https	O
://	O
gene	O
.	O
sfari	O
.	O
org	O
/	O
autdb	O
/	O
GS_Home	O
.	O
do	O

5https	O
://	O
gene	O
.	O
sfari	O
.	O
org	O
/	O
autdb	O
/	O
GS_Home	O
.	O
do	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Validation	O
of	O
differentially	O
expressed	O
genes	O
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

The	O
graph	O
shows	O
the	O
results	O
of	O
qRT	O
-	O
PCR	O
experiments	O
validating	O
an	O
increase	O
in	O
the	O
expression	O
of	O
Shank3	B-GP
,	O
Gpr85	B-GP
and	O
Clic6	B-GP
,	O
and	O
a	O
decrease	O
in	O
the	O
expression	O
of	O
Plk5	B-GP
in	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
compared	O
to	O
WT	O
mice	B-OG
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
4	O
–	O
6	O
animals	B-OG
per	O
genotype	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
,	O
unpaired	O
two	O
-	O
tailed	O
Student	O
’	O
s	O
t	O
-	O
test	O
).	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Detection	O
of	O
EGFP	B-GP
signal	O
from	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

To	O
test	O
whether	O
there	O
was	O
any	O
background	O
signal	O
from	O
the	O
striatal	O
sections	O
of	O
WT	O
and	O
Shank3	B-GP
TG	O
mice	B-OG
,	O
we	O
performed	O
IHC	O
experiments	O
only	O
with	O
the	O
secondary	O
antibodies	O
(	O
Alexa	O
Fluor	O
488	O
and	O
555	O
).	O

Under	O
the	O
scanning	O
condition	O
for	O
Alexa	O
Fluor	O
488	O
,	O
significant	O
amount	O
of	O
signal	O
(	O
potentially	O
from	O
the	O
EGFP	B-GP
-	O
Shank3	B-GP
proteins	O
)	O
was	O
detected	O
from	O
the	O
striatum	O
of	O
Shank3	B-GP
TG	O
,	O
but	O
not	O
WT	O
,	O
mice	B-OG
.	O

Meanwhile	O
,	O
no	O
signal	O
was	O
detected	O
for	O
Alexa	O
Fluor	O
555	O
from	O
both	O
WT	O
and	O
TG	O
striatum	O
.	O

DIC	O
,	O
differential	O
interference	O
contrast	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Normal	O
NeuN	B-GP
intensity	O
in	O
the	O
dorsal	O
striatum	O
of	O
Shank3	B-GP
TG	O
mice	B-OG
.	O

Representative	O
IHC	O
images	O
and	O
quantification	O
show	O
normal	O
NeuN	B-GP
intensity	O
in	O
the	O
DM	O
,	O
DL	O
and	O
DV	O
compartments	O
of	O
Shank3	B-GP
TG	O
striatum	O
.	O

Scale	O
bar	O
,	O
500	O
μm	O
.	O

DL	O
,	O
dorsolateral	O
;	O
DM	O
,	O
dorsomedial	O
;	O
DV	O
,	O
dorsoventral	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
5	O
animals	B-OG
per	O
genotype	O
;	O
P	O
>	O
0	O
.	O
05	O
,	O
unpaired	O
two	O
-	O
tailed	O
Student	O
’	O
s	O
t	O
-	O
test	O
).	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

